Processing 00000000.tx.1: Glucose-Induced Expression of the Cyclin-Dependent Protein Kinase 5 Activator p35 Involved in Alzheimers Disease Regulates Insulin Gene Transcription in Pancreatic -Cells Mariano Ubeda, Daniel M. 

Phrase: "Glucose-Induced Expression of the Cyclin-Dependent Protein Kinase 5 Activator p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1171362:expression protein [Genetic Function]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Involved in Alzheimers Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "Regulates"

Phrase: "Insulin Gene Transcription in Pancreatic -Cells Mariano Ubeda,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "Daniel M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Kemp and Joel F. 

Phrase: "Kemp"

Phrase: "and"

Phrase: "Joel F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: Habener Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Howard Hughes Medical Institute and Harvard Medical School, Boston, Massachusetts 02114 Address all correspondence and requests for reprints to: Joel F. 

Phrase: "Habener Laboratory of Molecular Endocrinology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Howard Hughes Medical Institute"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021622:institute [Organization]
   812   C0205476:Medical [Functional Concept]
   812   C1272753:Institute [Idea or Concept]
   812   C1551730:Hughes [Population Group]

Phrase: "and"

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02114"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Joel F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.4: Habener, M.D., Laboratory of Molecular Endocrinology, Massachusetts General Hospital, 55 Fruit Street, Wellman 306, Boston, Massachusetts 02114. 

Phrase: "Habener,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Laboratory of Molecular Endocrinology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "55 Fruit Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Wellman 306,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02114."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]
Processing 00000000.tx.5: E-mail: jhabener{at}partners.org .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  The deposition of amyloid within the insulin-producing islets of Langerhans in the pancreas is a common pathological finding in patients with type 2 diabetes. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "jhabener{at}partners.org .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The deposition of amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]

Phrase: "within the insulin-producing islets"

Phrase: "of Langerhans"

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a common pathological finding in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.6: Its relationship with age and the progression of the disease resembles the pathological deposition of -amyloid in the brains of Alzheimers patients. 

Phrase: "Its relationship with age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the progression of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0242656:Disease Progression [Pathologic Function]
           progression
   797   C1947900:Disease progression NOS [Finding]
   760   C0449258:Progression [Functional Concept]

Phrase: "resembles"

Phrase: "the pathological deposition of -amyloid in the brains of Alzheimers patients."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   754   C1705760:Amyloid Deposition [Finding]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: Endocrine cells of pancreatic islets and cells of neuronal lineages express a shared subset of specialized genes. 

Phrase: "Endocrine cells of pancreatic islets"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   811   C0734999:Pancreatic islet cell [Cell]
   806   C0229525:Endocrine Cells [Cell]
   797   C0022131:cells islets [Body Part, Organ, or Organ Component]
   764 E C1522529:Islet Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0014136:Endocrine [Body System]
   760   C0521425:Endocrine [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cells of neuronal lineages"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   802   C0282637:Lineages, Cell [Idea or Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "a shared subset of specialized genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]
Processing 00000000.tx.8: The hyperactivity of the cyclin-dependent protein kinase CDK5, involved in the development and differentiation of the nervous system, is associated with Alzheimers disease. 

Phrase: "The hyperactivity of the cyclin-dependent protein kinase CDK5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0424295:Hyperactivity, NOS [Finding]

Phrase: "involved in the development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "differentiation of the nervous system,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "is"

Phrase: "associated with Alzheimers disease."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.9: Overactivity of CDK5 occurs by proteolytic cleavage and cellular mislocalization of its activator, p35. 

Phrase: "Overactivity of CDK5"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0474395:overactivity [Finding]
   790   C1536696:Overactivity [Finding]
   718 E C0443272:Overactive [Qualitative Concept]

Phrase: "occurs by proteolytic cleavage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C0597304:Proteolytic [Molecular Function]
   770   C1330957:cleavage [Cell Function]
   770   C1709305:Occur [Activity]
   770   C1947941:proteolytic [Enzyme]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "cellular mislocalization of its activator,"

Phrase: "p35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]
Processing 00000000.tx.10: These alterations in p35/CDK5 signaling pathway may mediate, at least in part, the functional abnormalities characteristic of Alzheimers disease. 

Phrase: "These alterations in p35/CDK5 signaling pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "the functional abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "characteristic of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0599878:disease characteristic [Pathologic Function]
   770   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.11: In this study we report that both the p35 and CDK5 genes are expressed in insulin-producing -cells of the pancreas. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "both the p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1332735:CDK5 gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "expressed in insulin-producing -cells of the pancreas."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   750   C0030281:Insulin Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   744   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.12: We detect in -cells the formation of an active p35/CDK5 complex with specific kinase activity. 

Phrase: "We"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the formation of an active p35/CDK5 complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "with specific kinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.13: Notably, elevations of the extracellular concentration of glucose result in increases in p35 mRNA and protein levels that parallel elevations of p35/CDK5 activity. 

Phrase: "Notably,"

Phrase: "elevations of the extracellular concentration of glucose result"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0702240:elevations [Spatial Concept]
   711 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "in increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in p35 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "that parallel elevations of p35/CDK5 activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702240:elevations [Spatial Concept]
   714 E C0439775:Elevation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.14: Functional studies show that p35 stimulates the activity of the insulin promoter and that the stimulation requires CDK5 because stimulation is blocked by roscovitine, an inhibitor of CDK5 activity, a dominant negative form of CDK5, and small interfering RNAs against p35. 

Phrase: "Functional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "stimulates"

Phrase: "the activity of the insulin promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "requires"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "because"

Phrase: "stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "blocked by roscovitine,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "an inhibitor of CDK5 activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "a dominant negative form of CDK5,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1513916:Negative [Finding]
   753   C1522492:Form [Functional Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "small interfering RNAs against p35."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   828   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0521102:interfering [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.15: Our findings indicate that the expression of p35 and CDK5 in insulin-producing -cells ensembles a new signaling pathway, the activity of which is controlled by glucose, and its functional role may comprise the regulation of various biological processes in -cells, such as is the case for expression of the insulin gene.  

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CDK5 in insulin-producing -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1332735:CDK5 [Gene or Genome]

Phrase: "ensembles"

Phrase: "a new signaling pathway,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "the activity of which"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "controlled by glucose,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   882   C0332298:Controlled by [Functional Concept]
   841   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C2587213:Controlled [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "its functional role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1705810:Functional Role [Conceptual Entity]
           Role
   861   C0035820:Role [Social Behavior]

Phrase: "may"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the regulation of various biological processes in -cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   811   C1327622:Regulation of biological process [Biologic Function]
           Regulation
   767   C0678661:biological regulation [Biologic Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]

Phrase: "such as"

Phrase: "is"

Phrase: "the case for expression of the insulin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.16: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  DIABETES MELLITUS is an age-related disease manifested by glucose intolerance and premature vascular disease. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "DIABETES MELLITUS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "an age-related disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "manifested by glucose intolerance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0271650:Glucose Intolerance [Disease or Syndrome]
   833   C1280444:Manifested by [Qualitative Concept]
           manifested
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205319:manifested [Functional Concept]
   770   C0231199:Intolerance [Organism Function]
   770   C1744706:intolerance [Intellectual Product]
   770   C2355652:Intolerance [Organism Attribute]

Phrase: "and"

Phrase: "premature vascular disease."
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
   901   C0042373:Vascular disease [Disease or Syndrome]
   851 E C0018939:Blood disease NOS [Disease or Syndrome]
   851 E C1533163:Blood disease [Disease or Syndrome]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.17: Diabetes is increasing in epidemic proportions in populations throughout the world. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "increasing in epidemic proportions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0014499:Epidemic [Phenomenon or Process]
   770   C0442808:Increasing [Functional Concept]
   737 E C0442805:Increase [Functional Concept]
   737   C1709707:Proportion [Quantitative Concept]

Phrase: "in populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "throughout the world."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700280:World [Population Group]
Processing 00000000.tx.18: Diabetes is due to a failure of -cells in the endocrine pancreas (islets of Langerhans) to produce insulin in the amounts required to meet the bodys needs. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is due to a failure of -cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0007634:Cells [Cell]
   748   C0231174:Failure [Functional Concept]
   748   C0680095:failure [Individual Behavior]
   748   C3146286:Due [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in the endocrine pancreas"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0022131:Pancreas, Endocrine [Body Part, Organ, or Organ Component]
  1000   C1283884:Endocrine pancreas [Body Part, Organ, or Organ Component]
   861   C0014136:Endocrine [Body System]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C0521425:Endocrine [Functional Concept]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "insulin in the amounts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "meet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "the bodys needs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Needs [Qualitative Concept]
   861   C0686904:needs [Functional Concept]
Processing 00000000.tx.19: The major form of type 2, maturity-onset diabetes is obesity-related diabetes, so-called adipogenic diabetes. 

Phrase: "The major form of type 2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C3463805:Type of Form [Intellectual Product]
           form type
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "is"

Phrase: "obesity-related diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C2945676:obesity diabetes [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "so-called adipogenic diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.20: Individuals with adipogenic diabetes become insulin resistant and overproduce and oversecrete insulin (hyperinsulinemia). 

Phrase: "Individuals with adipogenic diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "become"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332325:Resistant [Functional Concept]
  1000   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "overproduce"

Phrase: "and"

Phrase: "oversecrete"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.21: In time, a subpopulation of adipogenic diabetic individuals develop endocrine pancreatic failure, a failure of the -cells to produce adequate amounts of insulin, resulting in persistently elevated blood glucose levels (hyperglycemia). 

Phrase: "In time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "a subpopulation of adipogenic diabetic individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1257890:Subpopulation [Population Group]

Phrase: "develop"

Phrase: "endocrine pancreatic failure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "a failure of the -cells to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]

Phrase: "produce"

Phrase: "adequate amounts of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "resulting in persistently elevated blood glucose levels"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   837   C0495706:Elevated blood glucose level [Finding]
   814   C0428554:blood glucose levels [Laboratory or Test Result]
           Glucose result - blood
   814   C0595877:elevated blood glucose [Finding]
   778   C0005802:Blood Glucose [Carbohydrate]
   778   C0332294:Resulting in [Functional Concept]
   778   C0428548:glucose levels [Laboratory or Test Result]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0229664:Blood [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0750508:persistently [Idea or Concept]
   748   C3163633:Elevated [Qualitative Concept]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C2825142:Result [Finding]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.22: Hyperglycemia accelerates the deterioration of -cell functioning, by so-called glucotoxicity, of unknown mechanisms. 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the deterioration of -cell functioning,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C0007613:Cell Function [Cell Function]
   812   C0542341:functioning [Functional Concept]
   779 E C0031843:function [Physiologic Function]
   779 E C0700205:FUNCTION [Classification]
   779 E C1705273:Function [Intellectual Product]

Phrase: "by so-called glucotoxicity,"

Phrase: "of unknown mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.23: Deposition of insoluble amylin fibers in the islets is implicated in -cell failure and is a pathological landmark of type 2 diabetes (1). 

Phrase: "Deposition of insoluble amylin fibers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "in the islets"

Phrase: "is"

Phrase: "implicated"

Phrase: "in -cell failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "is"

Phrase: "a pathological landmark of type 2 diabetes"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: Alzheimers disease is an age-related form of dementia due to a progressive loss of neuronal functioning, also characterized by the deposition of extracellular amyloid throughout the brain (amyloid plaques) and a significant decrease in brain mass. 

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "an age-related form of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "due to a progressive loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of neuronal functioning,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0542341:functioning [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]

Phrase: "also"

Phrase: "characterized by the deposition of extracellular amyloid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   774   C1705760:Amyloid Deposition [Finding]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0333562:Deposition [Functional Concept]
   748   C0521119:Extracellular [Cell Component]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1880022:Characterized [Activity]

Phrase: "throughout the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "a significant decrease in brain mass."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.25: An overactivity of the cyclin-dependent protein kinase CDK5 in the brain has been implicated in neuronal degeneration and the formation of neurofibrillary tangles due to hyperphosphorylation of essential neuronal proteins such as MAP and Tau (2). 

Phrase: "An overactivity of the cyclin-dependent protein kinase CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0474395:overactivity [Finding]
   742   C1536696:Overactivity [Finding]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in neuronal degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "the formation of neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "due to hyperphosphorylation"

Phrase: "of essential neuronal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as MAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: CDK5 is regulated by the neuron-specific and cyclin-related protein p35 (also known as p35Ncdk5a). 

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "is"

Phrase: "regulated by the neuron-specific"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0027882:Neuron [Cell]
   760   C0205369:Specific [Qualitative Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "cyclin-related protein p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3539715:p35 [Gene or Genome]

Phrase: "(also"

Phrase: "known as p35Ncdk5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205309:Known [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.27: During the development of Alzheimers disease, p35 is processed to a smaller protein, p25, which is a constitutive activator of CDK5. 

Phrase: "During the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "is"

Phrase: "processed to a smaller protein,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   781   C0033666:process protein [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
   760   C1522240:Processed [Phenomenon or Process]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "p25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p25 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "a constitutive activator of CDK5."
Processing 00000000.tx.28: The generation of p25 disrupts CDK5 localization and substrate preferences (2). 

Phrase: "The generation of p25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "CDK5 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "substrate preferences"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0558295:Preferences [Idea or Concept]
   827 E C1549513:Preference [Idea or Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.29: In addition, the expression of p25 in neurons results in a collapse of microtubules, neurite retraction, and apoptosis (2). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the expression of p25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "results in a collapse of microtubules,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0026046:Microtubules [Cell Component]
   753   C0036974:collapse [Pathologic Function]
   753   C0332521:Collapse [Phenomenon or Process]
   753   C0344329:Collapse [Finding]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1880118:COLLAPSE [Phenomenon or Process]
   753   C2825142:Result [Finding]

Phrase: "neurite retraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332523:Retraction [Finding]
   861   C2825977:Retraction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.30: Despite their endodermal origin, pancreatic endocrine cells share many molecular and cellular characteristics with neural ectoderm-derived neurons. 

Phrase: "Despite their endodermal origin,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]

Phrase: "pancreatic endocrine cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0229525:Endocrine Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014136:Endocrine [Body System]
   827   C0521425:Endocrine [Functional Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "many molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "cellular characteristics with neural ectoderm-derived neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.31: Several specialized genes are expressed in both the nervous system and insulin-producing -cells of the pancreas. 

Phrase: "Several specialized genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "expressed in both"

Phrase: "the nervous system"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0027763:Nervous System [Body System]
  1000   C0422837:NERVOUS SYSTEM [Finding]
  1000   C1269560:Nervous system [Body System]
   944 E C0205494:Neurologic [Qualitative Concept]
   907 E C0027855:Neurology [Biomedical Occupation or Discipline]
   888 E C2707261:Neurological [Clinical Attribute]
   861   C0027769:Nervous [Sign or Symptom]
   861   C0449913:System [Functional Concept]
   861   C0599851:Nervous [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
   745 E C0027740:Nerve [Tissue]
   745 E C0027757:NERVE [Tissue]
   745 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "insulin-producing -cells of the pancreas."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C0030281:Insulin Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.32: Genes such as enolase, tetanus toxin receptor, and the A2B5 antigen initially found in the nervous system were later found to be expressed in -cells (3). 

Phrase: "Genes such as enolase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "tetanus toxin receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0076207:tetanus toxin receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0039617:Tetanus Toxin [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "the A2B5 antigen initially"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C3641733:A2B5 Antigen [Immunologic Factor,Lipid]
   827   C0003320:Antigen [Immunologic Factor]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "found in the nervous system"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0027763:Nervous System [Body System]
   806   C0422837:NERVOUS SYSTEM [Finding]
   806   C1269560:Nervous system [Body System]
   760   C0027769:Nervous [Sign or Symptom]
   760   C0150312:Found [Quantitative Concept]
   760   C0449913:System [Functional Concept]
   760   C0599851:Nervous [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   751 E C0205494:Neurologic [Qualitative Concept]
   726 E C0243095:Find [Finding]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]

Phrase: "were"

Phrase: "later"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed"

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.33: Another group of genes normally expressed in islet of Langerhans has been shown to be present in the nervous system. 

Phrase: "Another group of genes normally"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "expressed in islet of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0022131:Islet of Langerhans [Body Part, Organ, or Organ Component]
           islet langerhans

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in the nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.34: Some of these genes are only temporally expressed in the developing brain, such as insulin and the transcription factor IDX-1 (islet and duodenum homeobox-1) [PDX-1 (pancreatic and duodenal homeobox-1)] (4, 5, 6, 7), whereas other genes are permanently expressed, such as the genes for ATP-sensitive K+ channel (8, 9) and the LIM (Lin-11, Isl-1, and Mec-3) homeodomain protein islet-1 (10). 

Phrase: "Some of these genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "are"

Phrase: "only temporally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "expressed in the developing brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "such as insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the transcription factor IDX-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1826562:IDX-1 [Gene or Genome]
   812   C0040649:Transcription [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(islet"

Phrase: "and"

Phrase: "duodenum homeobox-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0013303:Duodenum [Body Part, Organ, or Organ Component]
   827   C0242303:Homeo Box [Gene or Genome]
   827   C0598306:Homeo Box [Spatial Concept]
   827   C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "[PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "(pancreatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "duodenal homeobox-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   827   C0242303:Homeo Box [Gene or Genome]
   827   C0598306:Homeo Box [Spatial Concept]
   755 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "]"

Phrase: "(4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "permanently"

Phrase: "expressed"

Phrase: ","

Phrase: "such as the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "for ATP-sensitive K+ channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1708601:K' [Quantitative Concept]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "and"

Phrase: "the LIM (Lin-11,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449205:LIM [Body Location or Region]
   827   C0861352:LIN [Neoplastic Process]
   827   C1538613:LIM [Gene or Genome]

Phrase: "Isl-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416480:ISL1 [Gene or Genome]
   861   C0020750:ISL [Geographic Area]

Phrase: "and"

Phrase: "Mec-3"

Phrase: ")"

Phrase: "homeodomain protein islet-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416480:ISLET 1 [Gene or Genome]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.35: Because of the similarities between neurons and pancreatic -cells and between the neural degeneration of Alzheimers disease and the deterioration of -cell functioning in adipogenic diabetes, we reasoned that p35/CDK5 may also be expressed in -cells and contribute to the pathogenesis of diabetes mellitus. 

Phrase: "Because of the similarities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "between neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and between the neural degeneration of Alzheimers disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0027746:neural degeneration [Cell or Molecular Dysfunction]
   744   C0011164:Degeneration [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0599851:Neural [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "the deterioration of -cell functioning in adipogenic diabetes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   754   C0007613:Cell Function [Cell Function]
   744   C0542341:functioning [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that p35/CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332735:CDK5 [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "expressed"

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "contribute to the pathogenesis of diabetes mellitus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.36: This idea was reinforced by the recent findings of statistical correlations between Alzheimer-type dementia and diabetes mellitus in longitudinal population-based cohort studies (11, 12), and the fact that the yeast ortholog of CDK5, Pho85, is involved in metabolic control (13, 14). 

Phrase: "This idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "was"

Phrase: "reinforced by the recent findings of statistical correlations"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   754   C0010101:statistical correlation [Intellectual Product,Research Activity]
   744   C0038215:Statistical [Occupation or Discipline]
   744   C0332185:Recent [Temporal Concept]
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711   C1707520:Correlation [Qualitative Concept]
   711 E C2825141:Finding [Finding]

Phrase: "between Alzheimer-type dementia"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0002395:Dementia, Alzheimer Type [Disease or Syndrome]
           Alzheimer's Dementia
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0332307:Type [Qualitative Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1547052:*Type [Quantitative Concept]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "diabetes mellitus in longitudinal population-based cohort studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   744   C0011847:Diabetes [Disease or Syndrome]

Phrase: "(11,"

Phrase: "12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the fact"

Phrase: "that"

Phrase: "the yeast ortholog of CDK5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1335144:Ortholog [Gene or Genome]

Phrase: "Pho85,"

Phrase: "is"

Phrase: "involved in metabolic control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1513158:Metabolic Control [Molecular Function]
   770   C0243148:control [Qualitative Concept]
   770   C0311400:Metabolic [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1524026:Metabolic [Cell Function]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2707259:Metabolic [Clinical Attribute]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.37: We further hypothesized that continuous elevation of serum glucose may dysregulate CDK5 activity and thereby may provide an explanation of how persistent hyperglycemia may contribute to the progressive failure of -cell functioning in diabetes. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "hypothesized"

Phrase: "that continuous elevation of serum glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "may"

Phrase: "dysregulate"

Phrase: "CDK5 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an explanation of how persistent hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "may"

Phrase: "contribute to the progressive failure of -cell functioning"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   754   C0007613:Cell Function [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0205329:Progressive [Functional Concept]
   744   C0231174:Failure [Functional Concept]
   744   C0542341:functioning [Functional Concept]
   744   C0680095:failure [Individual Behavior]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1880177:Contribute [Activity]
   744   C1948049:Cell [Spatial Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.38: To determine whether the p35/CDK5 has a possible functional role on -cell activity we examined p35/CDK5 in -cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the p35/CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332735:CDK5 [Gene or Genome]

Phrase: "has"

Phrase: "a possible functional role on -cell activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "p35/CDK5 in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.39: Our studies comprise mRNA detection by RT-PCR, cDNA cloning, and kinase activity assays. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "mRNA detection by RT-PCR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "cDNA cloning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "kinase activity assays."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1150423:kinase activity [Molecular Function]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.40: Furthermore, functional studies in cultured clonal INS-1 cells as well as experiments to assure specificity were performed. 

Phrase: "Furthermore,"

Phrase: "functional studies in cultured clonal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as well as"

Phrase: "experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "assure"

Phrase: "specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.41: Our findings indicate that 1) pancreatic islets and cultured -cells express both p35 and CDK5; 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cultured -cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "express"

Phrase: "both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.42: 2) elevations of the concentration of glucose in the culture medium result in induction of p35 expression that is translated into activation of the p35/CDK5 kinase activity; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "elevations of the concentration of glucose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0702240:elevations [Spatial Concept]
   719 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "in the culture medium result"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
   734   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of p35 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "is"

Phrase: "translated into activation of the p35/CDK5 kinase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C1150423:kinase activity [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0040710:translated [Occupational Activity]
   742   C0205177:Activity [Functional Concept]
   742   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1332735:CDK5 [Gene or Genome]
   742   C1561536:*Activity [Idea or Concept]
   742   C1879547:Activation [Activity]
   742   C3539715:p35 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.43: and 3) the expression of p35 and the activation of p35/CDK5 enhance transcriptional activation of the insulin gene. 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "the expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the activation of p35/CDK5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "transcriptional activation of the insulin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162493:Transcriptional Activation [Genetic Function]
   783   C0017255:Gene Activation [Genetic Function]
   753   C1879547:Activation [Activity]
Processing 00000000.tx.44: This effect on the insulin gene promoter is specific because it is prevented by roscovitine, an inhibitor of CDK5 activity, by a dominant negative form of CDK5, and by the use of small interfering RNA (siRNA), which acts by destabilizing the p35 mRNA and thereby reducing the level of p35 protein.  

Phrase: "This effect on the insulin gene promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "prevented by roscovitine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "an inhibitor of CDK5 activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "by a dominant negative form"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   827   C0205160:Negative [Qualitative Concept]
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1513916:Negative [Finding]
   827   C1522492:Form [Functional Concept]
   827   C1527180:Dominant [Functional Concept]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]

Phrase: "of CDK5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "and by the use of small interfering RNA (siRNA),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1524063:Use of [Functional Concept]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C0521102:interfering [Qualitative Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "acts by destabilizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "the p35 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "thereby"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the level of p35 protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.45: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Chemicals, antibodies, and oligonucleotides DNA-modifying enzymes were purchased from New England Biolabs (Beverly, MA) and Roche (Indianapolis, IN). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Chemicals,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "oligonucleotides DNA-modifying enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "purchased from New England Biolabs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027965:New England [Geographic Area]
   760   C0014282:England [Geographic Area]
   760   C0205314:New [Temporal Concept]
   760   C0869011:purchased [Activity]

Phrase: "(Beverly,"

Phrase: "MA)"

Phrase: "and"

Phrase: "Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "(Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.46: Tissue culture media, serum and other reagents were obtained from Life Technologies, Inc. 

Phrase: "Tissue culture media,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   901   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   901   C0040284:Tissue culture [Laboratory Procedure]
   827   C0009458:Media [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0040300:Tissue [Tissue]
   827   C0162867:Media [Tissue]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1254021:Media [Tissue]
   827   C1547928:Tissue [Intellectual Product]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "obtained from Life Technologies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.47: (Grand Island, NY), and roscovitine was purchased from Calbiochem (San Diego, CA). 

Phrase: "(Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "roscovitine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.48: Antibodies against p35 (C-19) and CDK5 (C-8) were purchased from Santa Cruz Biotechnology, Inc. 

Phrase: "Antibodies against p35"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(C-19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "(C-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Santa Cruz Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.49: (Santa Cruz, CA). 

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.50: Oligonucleotides were synthesized at the Molecular Biology Core Facility of Massachusetts General Hospital. 

Phrase: "Oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized at the Molecular Biology Core Facility of Massachusetts General Hospital."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   756   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   756   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   738   C0005532:Biology [Biomedical Occupation or Discipline]
   738   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   738   C0024874:Massachusetts [Geographic Area]
   738   C0205246:General [Spatial Concept]
   738   C0444669:Core [Spatial Concept]
   738   C1167518:core [Cell Component]
   738   C1510665:Hospital [Qualitative Concept]
   738   C1521991:Molecular [Qualitative Concept]
   738   C1547538:Facility [Idea or Concept]
   738   C1553889:General [Idea or Concept]
   738   C1706352:Core [Medical Device]
   738   C1882467:Core [Manufactured Object]
   738   C1883254:Synthesized [Activity]
   738   C3274653:Core [Body Substance]
Processing 00000000.tx.51: siRNAs were purchased from Dharmacon Research, Inc. 

Phrase: "siRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "purchased from Dharmacon Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.52: (Lafayette, CO). 

Phrase: "(Lafayette,"

Phrase: "CO"

Phrase: ")."
Processing 00000000.tx.53: Cell lines and tissue culture Rat INS-1 cells (provided by C. Wollheim, Geneva, Switzerland; passages 99110) were cultured in RPMI 1640 medium containing 10% fetal calf serum, 10 mmol/liter HEPES, 11.1 mmol/liter glucose, 1 mmol/liter sodium pyruvate, 50 mol/liter 2-mercaptoethanol, 100 U/ml penicillin G, and 100 mg/ml streptomycin. 

Phrase: "Cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "tissue culture Rat INS-1 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1514732:Rat-1 Cells [Cell]
           Rat-1
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]

Phrase: "("

Phrase: "provided by C. Wollheim,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "Geneva,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "; passages 99110"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "cultured in RPMI 1640 medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "10 mmol/liter HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "11.1 mmol/liter glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "1 mmol/liter sodium pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   804   C0034354:pyruvate [Organic Chemical]
   804   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "50 mol/liter 2-mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "100 U/ml penicillin G,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1532633:U/g [Quantitative Concept]
   875   C2608091:U/g [Quantitative Concept]
   853   C1637390:mL/g [Quantitative Concept]
   840   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   804   C0030842:Penicillin [Antibiotic,Organic Chemical]
   804   C0220892:Penicillin [Antibiotic,Organic Chemical]
   804   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "100 mg/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.54: HeLa cells and NIH-3T3 fibroblasts were cultured in DMEM containing 10% fetal calf serum, 100 U/ml penicillin G, and 100 mg/ml streptomycin. 

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "NIH-3T3 fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1257739:NIH/3T3 [Cell]
   827   C0016030:Fibroblasts [Cell]
   827   C0027468:NIH [Health Care Related Organization]

Phrase: "were"

Phrase: "cultured in DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "100 U/ml penicillin G,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1532633:U/g [Quantitative Concept]
   875   C2608091:U/g [Quantitative Concept]
   853   C1637390:mL/g [Quantitative Concept]
   840   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   804   C0030842:Penicillin [Antibiotic,Organic Chemical]
   804   C0220892:Penicillin [Antibiotic,Organic Chemical]
   804   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "100 mg/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.55: Cells were maintained at 37 C in a humidified incubator gassed with 5% CO2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained at 37 C in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "a humidified incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021178:Incubator [Manufactured Object]

Phrase: "gassed with 5% CO2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2347816:Co2+ [Element, Ion, or Isotope]
   737   C0017110:Gas [Chemical Viewed Structurally]
   737   C0596601:Gas [Sign or Symptom]
Processing 00000000.tx.56: Cell cultures were passaged by trypsinization and subcultured every 5 d. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "passaged by trypsinization"

Phrase: "and"

Phrase: "subcultured"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0200940:Subculture [Laboratory Procedure]
   966   C0699799:subculture [Population Group]

Phrase: "every 5 d."
Processing 00000000.tx.57: Animals and human tissue sources Male Wistar rats, 89 wk old and weighing 200250 g (The Jackson Laboratory, Bar Harbor, ME), were obtained for preparation of pancreatic tissue sections for immunocytochemistry. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "human tissue sources Male Wistar rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034716:Rats, Wistar [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
   799   C2700262:Wistar [Mammal]

Phrase: "89 wk old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "and"

Phrase: "weighing 200250 g ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "The Jackson Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "obtained for preparation of pancreatic tissue sections"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   774   C0200728:Tissue Preparation [Laboratory Procedure]
   762   C2316368:Tissue section [Tissue]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0040300:Tissue [Tissue]
   748   C0455052:Preparation [Health Care Activity]
   748   C1301820:Obtained [Functional Concept]
   748   C1521827:Preparation [Functional Concept]
   748   C1547928:Tissue [Intellectual Product]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]
   714 E C1706701:Obtain [Activity]

Phrase: "for immunocytochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]
Processing 00000000.tx.58: Purified human islets were obtained from the islet distribution programs of Cell Transplant Center, Diabetes Research Institute, University of Miami School of Medicine (Miami, FL), and Juvenile Diabetes Foundation Center for Islet Transplantation, Harvard Medical School (Boston, MA). 

Phrase: "Purified human islets"

Phrase: "were"

Phrase: "obtained from the islet distribution"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0520511:distribution [Idea or Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1704711:Distribution [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "programs of Cell Transplant Center,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0206152:Transplant, Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0040732:Transplant [Therapeutic or Preventive Procedure]
   760   C0205099:Center [Spatial Concept]
   760   C0332835:Transplant [Tissue]
   760   C0376691:Programs [Intellectual Product]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1709697:Program [Conceptual Entity]
   760   C1948049:Cell [Spatial Concept]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "Diabetes Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "University of Miami School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "(Miami,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551421:Miami [Population Group]

Phrase: "FL),"

Phrase: "and"

Phrase: "Juvenile Diabetes Foundation Center for Islet Transplantation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.59: Thoroughly washed islets were handpicked before performing RNA isolation and protein extraction for Western blot and kinase assays. 

Phrase: "Thoroughly washed islets"

Phrase: "were"

Phrase: "handpicked before performing RNA isolation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "protein extraction for Western blot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "kinase assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.60: Animal experiments were conducted in accordance with NIH guidelines for the care and use of laboratory animals and with approval from the Massachusetts General Hospital institutional animal care and use committee. 

Phrase: "Animal experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0205664:Animal Experiments [Research Activity]
   861   C0003062:Animal [Animal]
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "conducted in accordance with NIH guidelines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027468:NIH [Health Care Related Organization]
   753   C0162791:Guidelines [Intellectual Product]
   753   C0220845:guidelines [Intellectual Product]
   753   C0282423:guidelines [Intellectual Product]
   719   C0004927:Conduct [Individual Behavior]

Phrase: "for the care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "use of laboratory animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "and with approval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205540:Approval [Qualitative Concept]
   790   C1515981:And [Idea or Concept]
   790   C2346845:Approval [Intellectual Product]

Phrase: "from the Massachusetts General Hospital institutional animal care"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C1552318:General Care [Intellectual Product]
   876   C1552332:General Care [Intellectual Product]
   858   C0259945:Hospital care [Health Care Activity]
   839   C0868975:Institutional care [Health Care Activity]
   827   C0178478:animal care [Occupation or Discipline]
   799   C1947933:Care [Activity]

Phrase: "and"

Phrase: "use committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.61: Plasmid DNA constructs A rat p35 expression plasmid was constructed by RT-PCR amplification of the rat p35 coding sequence from INS-1 cells total RNA, maintaining its own Kozak sequence and inserting it into the pCR3 vector by TA cloning. 

Phrase: "Plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "A rat p35 expression plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed by RT-PCR amplification of the rat p35 coding sequence"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   756   C0079941:Coding Sequence [Gene or Genome]
   756   C0599161:RT-PCR [Molecular Biology Research Technique]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0009219:Coding [Occupational Activity]
   738   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0677874:pCR [Finding]
   738   C1517480:Amplification [Molecular Biology Research Technique]
   738   C1519249:Sequence [Functional Concept]
   738   C1521871:Amplification [Phenomenon or Process]
   738   C1705759:Amplification [Cell or Molecular Dysfunction]
   738   C3539715:p35 [Gene or Genome]
   704 E C0805701:Code [Intellectual Product]
   704   C2827421:Construct [Classification]

Phrase: "from"

Phrase: "INS-1 cells total RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "its own Kozak sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "inserting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441587:Insert [Health Care Activity]
   966   C1743766:Insert [Medical Device]
   966   C1883719:Insert [Functional Concept]

Phrase: "it into the pCR3 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "by TA cloning."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]
Processing 00000000.tx.62: The integrity of the construct was verified by DNA sequencing and Western blot detection of the corresponding expressed protein after transfection. 

Phrase: "The integrity of the construct"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "verified by DNA sequencing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1711411:Verified [Functional Concept]

Phrase: "and"

Phrase: "Western blot detection of the corresponding expressed protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.63: Once the sequence was confirmed the same amplified cDNA was inserted in-frame into the pCMV-tag2 vector (Stratagene, La Jolla, CA) containing a Flag tag in its amino-terminal domain. 

Phrase: "Once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the same amplified cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "in-frame into the pCMV-tag2 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080089:Frame [Nucleotide Sequence]
   748   C0180979:Frame [Medical Device]
   748   C1705858:Frame [Manufactured Object]

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a Flag tag in its amino-terminal domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0037293:Tag [Neoplastic Process]
   744   C0181496:Tag [Manufactured Object]
   744   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.64: A similar approach was used to construct an expression plasmid for rat CDK5 and to create a dominant negative version of CDK5. 

Phrase: "A similar approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "an expression plasmid for rat CDK5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a dominant negative version of CDK5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]
Processing 00000000.tx.65: The latter was generated by substituting the GAT codon at position 144 for AAT through the use of the QuikChange kit (Stratagene, La Jolla, CA) as previously described by Van den Heuvel and Harlow (15). 

Phrase: "The latter"

Phrase: "was"

Phrase: "generated by substituting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "the GAT codon at position 144"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0009221:Codon [Nucleotide Sequence]
   753   C1095825:Codon [Plant]

Phrase: "for AAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3537219:AAT [Gene or Genome]

Phrase: "through the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the QuikChange kit (Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: "as"

Phrase: "previously"

Phrase: "described by Van den Heuvel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0178587:DEN [Quantitative Concept]
   760   C0557775:Van [Manufactured Object]
   760   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Harlow"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.66: The 410 rat insulin-1 promoter luciferase construct was provided by Dr. 

Phrase: "The 410 rat insulin-1 promoter luciferase construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.67: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.68: German (University of San Francisco, San Francisco, CA). 

Phrase: "German"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556085:German [Population Group]

Phrase: "(University of San Francisco,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036152:San Francisco [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1826357:San [Gene or Genome]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.69: RT, amplification by PCR, and Southern blot analysis Total cellular RNA (5 g) dissolved in 10 l H2O was combined with 0.5 g oligo(deoxythymidine) (Life Technologies, Inc.) and heated to 65 C for 10 min, then cooled on ice. 

Phrase: "RT,"

Phrase: "amplification by PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Southern blot analysis Total cellular RNA (5 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0439267:g% [Quantitative Concept]

Phrase: "dissolved in 10 l H2O"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1549535:Dissolve [Functional Concept]

Phrase: "was"

Phrase: "combined with 0.5 g oligo(deoxythymidine"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0444499:0/5 [Quantitative Concept]
   774   C0069423:oligo(G) [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0028953:Oligo [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0045143:oligo [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0086126:Deoxythymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205195:Combined [Qualitative Concept]
   748   C0439267:g% [Quantitative Concept]
   714 E C0336789:Combine [Manufactured Object]

Phrase: ")"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "and"

Phrase: "heated to 65 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450385:65 [Intellectual Product]
   737   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cooled on ice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C1548792:Cool [Qualitative Concept]
Processing 00000000.tx.70: RT buffer, deoxy-NTPs (50 M each), dithiothreitol (5 mM), H2O, and 50 U SuperScript II enzyme (Life Technologies, Inc.) were incubated at 42 C for 40 min in a 40-l reaction. 

Phrase: "RT buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "deoxy-NTPs"

Phrase: "(50 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "each"

Phrase: ")"

Phrase: ","

Phrase: "dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(5 mM"

Phrase: ")"

Phrase: ","

Phrase: "H2O,"

Phrase: "and"

Phrase: "50 U SuperScript II enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "were"

Phrase: "incubated at 42 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 40 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in a 40-l reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.71: PCRs were carried out using 2 l cDNA template, 20 pmol each of forward and reverse primers, 0.2 M each of deoxy-NTPs, 1x buffer, and 2.5 U thermostable Taq polymerase (TaKaRa Biomedical, Inc., Berkeley, CA) in a 100-l reaction volume. 

Phrase: "PCRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   966   C0677874:pCR [Finding]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2 l cDNA template,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0728990:TEMPLATE [Medical Device]
   812   C1514575:Template [Conceptual Entity]
   812   C1705542:Template [Idea or Concept]

Phrase: "20 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "each of forward"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439780:Forward [Spatial Concept]
   790   C1457900:Each [Quantitative Concept]

Phrase: "and"

Phrase: "reverse primers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.2 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "each of deoxy-NTPs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]
   770   C1457900:Each [Quantitative Concept]

Phrase: "1x buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "2.5 U thermostable Taq polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(TaKaRa Biomedical, Inc.,"

Phrase: "Berkeley,"

Phrase: "CA) in a 100-l reaction volume."
Processing 00000000.tx.72: Amplifications were performed with 30 cycles of 30-sec denaturation at 95 C, 30-sec annealing at 55 C, and 1-min extension at 72 C. 

Phrase: "Amplifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1517480:Amplification [Molecular Biology Research Technique]
   966   C1521871:Amplification [Phenomenon or Process]
   966   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "performed with 30 cycles of 30-sec denaturation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   750   C2348029:cycle/sec [Quantitative Concept]
   744   C0301642:Denaturation [Molecular Function]
   744   C0884358:Performed [Functional Concept]
   711   C1511572:Cycle [Temporal Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at 95 C,"

Phrase: "30-sec annealing at 55 C,"

Phrase: "and"

Phrase: "1-min extension at 72 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231448:Extension [Functional Concept]
   753   C1880641:Extension [Conceptual Entity]
Processing 00000000.tx.73: Sense orientation primer for the rat p35 were: RP35-1, 5'-CGCGCAGTGGCACCATGGGCACGGTGCTGTCCCTG-3'; 

Phrase: "Sense orientation primer for the rat p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: ":"

Phrase: "RP35-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1853214:RP35 [Disease or Syndrome]
   861   C2828626:RP35 [Gene or Genome]

Phrase: "5'-CGCGCAGTGGCACCATGGGCACGGTGCTGTCCCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.74: and nested, RP35-12, 5'-TCCCCCAGCTATCGAAAGGCCACAC-3'. 

Phrase: "and"

Phrase: "nested, RP35-12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1853214:RP35 [Disease or Syndrome]
   827   C2828626:RP35 [Gene or Genome]

Phrase: "5'-TCCCCCAGCTATCGAAAGGCCACAC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.75: The sequence of the antisense primers was: RP35-2, 5'-GGAGCGGTCCACGCTGCGCAGCCAGAGCACGGGGT-3'; 

Phrase: "The sequence of the antisense primers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: ":"

Phrase: "RP35-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1853214:RP35 [Disease or Syndrome]
   861   C2828626:RP35 [Gene or Genome]

Phrase: "5'-GGAGCGGTCCACGCTGCGCAGCCAGAGCACGGGGT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.76: and nested: RP35-22, 5'-CGTTGGGGACAAGTGCTTCAGGCGG-3'. 

Phrase: "and"

Phrase: "nested"

Phrase: ":"

Phrase: "RP35-22,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1853214:RP35 [Disease or Syndrome]
   861   C2828626:RP35 [Gene or Genome]

Phrase: "5'-CGTTGGGGACAAGTGCTTCAGGCGG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.77: Confirmation of the identity of the amplified band was achieved by Southern blot analysis after transferring the amplified DNA onto a nitrocellulose filter and hybridization with a 32P-labeled internal oligonucleotide probe RP35-3 (5'-GGTTCTCATTGTTGAGGTGCGCGATGTTGCTCTGGTAGCTGCTGTTGGGCTGCGCCTTCTTGGAGTTC-3'). 

Phrase: "Confirmation of the identity of the amplified band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   744   C0750484:Confirmation [Idea or Concept]

Phrase: "was"

Phrase: "achieved by Southern blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   862   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1710133:Southern [Spatial Concept]

Phrase: "after transferring"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1540850:Transferring [Activity]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "the amplified DNA onto a nitrocellulose filter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "hybridization with a 32P-labeled internal oligonucleotide probe RP35-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0020202:Hybridisation [Genetic Function]
   739   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(5'-GGTTCTCATTGTTGAGGTGCGCGATGTTGCTCTGGTAGCTGCTGTTGGGCTGCGCCTTCTTGGAGTTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.78: For the human p35 sequence, the sense primer was HP351 (5'-GCGCGCAGCAGCACCATGGGCACGGTGCTGTCC-3'), and the antisense primer was HP35-2 (5'-TGCTCACCGATCCAGGCCTAGGAGGAGCCGCTT-3'). 

Phrase: "For the human p35 sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "the sense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "HP351"

Phrase: "(5'-GCGCGCAGCAGCACCATGGGCACGGTGCTGTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the antisense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "HP35-2"

Phrase: "(5'-TGCTCACCGATCCAGGCCTAGGAGGAGCCGCTT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.79: Immunocytochemistry Cryosections of 6 m were prepared from rat pancreases and fixed with 4% paraformaldehyde in PBS. 

Phrase: "Immunocytochemistry Cryosections of 6 m"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0085188:cryosection [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from rat pancreases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   737   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   737   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.80: Sections were first blocked with 3% normal donkey serum for 45 min at room temperature. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "blocked with 3% normal donkey serum"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0028778:Blocked [Pathologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0324145:Donkey [Mammal]
   753   C0332206:Blocked [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.81: Subsequently, they were incubated with primary antibody at a 1:500 dilution overnight in a cold room (see Materials and Methods). 

Phrase: "Subsequently,"

Phrase: "they"

Phrase: "were"

Phrase: "incubated with primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at a 1"

Phrase: ":"

Phrase: "500 dilution overnight in a cold room"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079240:Dilution [Laboratory Procedure]
   748   C1948037:Dilution [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: The next day the sections were rinsed in PBS and incubated with the corresponding Cy3- and Cy2-labeled secondary donkey antisera for 1 h at room temperature. 

Phrase: "The next day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "rinsed in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated with the corresponding Cy3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "Cy2-labeled secondary donkey antisera for 1 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.83: Slides were then washed with PBS and mounted using fluorescent mounting medium (Kirkegaard & Perry Laboratories, Gaithersburg, MD). 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "mounted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescent mounting medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
   793   C0181909:Mount [Medical Device]
   793   C0449878:mount [Finding]

Phrase: "(Kirkegaard & Perry Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.84: Fluorescent images were obtained using a epifluorescence microscope (Carl Zeiss, Inc., New York, NY) equipped with an TEC-470 CCD camera (Optronics International, Chelmsford, MA). 

Phrase: "Fluorescent images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a epifluorescence microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "(Carl Zeiss,"

Phrase: "Inc.,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "equipped with an TEC-470 CCD camera"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0598124:CCD camera [Manufactured Object]
   748   C0179533:Camera [Medical Device]
   748   C1654607:Camera [Eukaryote]
   748   C1706254:CAMERA [Medical Device]

Phrase: "(Optronics International, Chelmsford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.85: Immunoprecipitation and kinase assay We followed the protocol of Nikolic and Tsai (16) for immunoprecipitation and detection of p35/CDK5 activity. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "We"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the protocol of Nikolic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442711:Protocol [Intellectual Product]
   770   C1507394:Protocol [Intellectual Product]
   770   C1522729:Protocol [Intellectual Product]
   770   C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "Tsai"

Phrase: "(16"

Phrase: ")"

Phrase: "for immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "detection of p35/CDK5 activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2265875:detection of activity [Molecular Function]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.86: Briefly, the cells or tissues were homogenized in lysis buffer A, containing 20 mM Tris-HCl (pH 7.2), 2 mM MgCl2, 0.5% Nonidet P-40, 150 mM NaCl, and 1 mM dithiothreitol. 

Phrase: "Briefly,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "homogenized in lysis buffer A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
   760   C1536403:lysis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mM Tris-HCl (pH 7.2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "2 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.5% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "1 mM dithiothreitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.87: The following protease and phosphatase inhibitors were also added: phenylmethylsulfonylfluoride (1 mM), leupeptin (2 g/ml), aprotinin (1 g/ml), NaF (5 mM), and NaVO4 (1 mM). 

Phrase: "The following protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "and"

Phrase: "phosphatase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ":"

Phrase: "phenylmethylsulfonylfluoride"

Phrase: "(1 mM"

Phrase: ")"

Phrase: ","

Phrase: "leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(2 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(1 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "NaF (5 mM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "NaVO4"

Phrase: "(1 mM"

Phrase: ")."
Processing 00000000.tx.88: For p35 immunoprecipitation, cellular extracts containing 1.5 mg protein were incubated with 3 l of the corresponding p35 (C-19) antibody at 4 C overnight and then with 100 l protein A-Sepharose (10 mg/ml) for an additional hour at 4 C. 

Phrase: "For p35 immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.5 mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated with 3 l of the corresponding p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1439852:Incubated [Laboratory Procedure]
   744   C3539715:p35 [Gene or Genome]

Phrase: "(C-19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "antibody at 4 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "then with 100 l protein A-Sepharose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0075172:protein A-sepharose [Carbohydrate]
   778   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Sepharose [Carbohydrate]
   748   C1883708:Then [Temporal Concept]

Phrase: "(10 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) for an additional hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0439391:mL/hour [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.89: The samples were washed three times with lysis buffer and used for determination of kinase activity after two additional washes in kinase buffer. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with lysis buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "used for determination of kinase activity"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C1150423:kinase activity [Molecular Function]
   767   C1524063:Use of [Functional Concept]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1148554:determination [Laboratory Procedure]
   753   C1273517:used [Finding]
   753   C1561536:*Activity [Idea or Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "after two additional washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0441648:Wash [Activity]

Phrase: "in kinase buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.90: The in vitro kinase reaction was performed at 30 C for 30 min in kinase buffer [50 mM HEPES (pH 7.0), 10 mM MgCl2, 5 mM MnCl2, and 1 mM dithiothreitol] containing 1 Ci [-32P]ATP and 5 g histone H1 in a 50-l reaction volume. 

Phrase: "The in vitro kinase reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "performed at 30 C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in kinase buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "[50 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "10 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 mM MnCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0065642:MnCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "]"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 Ci [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "5 g histone H1 in a 50-l reaction volume."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0019644:Histone H1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1415389:H1.5 [Gene or Genome]
Processing 00000000.tx.91: A equal volume of Laemmli loading buffer was added to stop the reaction, and samples were loaded in a 10% SDS-PAGE after boiling for 5 min. 

Phrase: "A equal volume of Laemmli loading buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0449468:*Volume [Quantitative Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1947925:Stop [Activity]
  1000   C2746065:Stop [Temporal Concept]

Phrase: "the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "loaded in a 10% SDS-PAGE"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C1704732:Page [Intellectual Product]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "after boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.92: Gels were dried and exposed for autoradiography. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "exposed for autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0332157:Exposed [Clinical Attribute]
Processing 00000000.tx.93: Western blot assays Protein extracts were run in a 10% SDS-PAGE gel (200 g protein/lane) and transferred onto a nitrocellulose membrane at 4 C overnight. 

Phrase: "Western blot assays Protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "run in a 10% SDS-PAGE gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0017243:Gel [Biomedical or Dental Material]
   795   C1382104:Gel [Substance]

Phrase: "(200 g protein/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "transferred onto a nitrocellulose membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "at 4 C overnight."
Processing 00000000.tx.94: Blocking was performed for 1 h in 10% nonfat milk and 0.1% Tween 20 at room temperature. 

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "was"

Phrase: "performed for 1 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in 10% nonfat milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "and"

Phrase: "0.1% Tween 20 at room temperature."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   778   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   751 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]
   748   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   748   C1547703:Room [Spatial Concept]
Processing 00000000.tx.95: The membranes were then incubated for an additional 1 h in 1% nonfat milk and 0.1% Tween 20 with the primary antibody at a 1:200 dilution for p35 and CDK5 antibody and a 1:1000 dilution for insulin antibody. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for an additional 1 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0700308:h 1 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1524062:Additional [Functional Concept]

Phrase: "in 1% nonfat milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "and"

Phrase: "0.1% Tween 20 with the primary antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   743 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]

Phrase: "at a 1"

Phrase: ":"

Phrase: "200 dilution for p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079240:Dilution [Laboratory Procedure]
   770   C1948037:Dilution [Functional Concept]

Phrase: "and"

Phrase: "CDK5 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "a 1"

Phrase: ":"

Phrase: "1000 dilution for insulin antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.96: An additional incubation with a horseradish peroxidase-conjugated secondary antibody was also performed at room temperature for 1 h. 

Phrase: "An additional incubation with a horseradish peroxidase-conjugated secondary antibody"

Phrase: "was"

Phrase: "also"

Phrase: "performed at room temperature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.97: After three consecutive washes of 15 min each, the reactive proteins were developed with the the luminescent enhanced chemiluminescence system from Amersham Pharmacia Biotech (Arlington Heights, IL). 

Phrase: "After three consecutive washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0441648:Wash [Activity]

Phrase: "of 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "each,"

Phrase: "the reactive proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205332:Reactive [Qualitative Concept]

Phrase: "were"

Phrase: "developed with the"

Phrase: "the luminescent enhanced chemiluminescence system from Amersham Pharmacia Biotech"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0449913:System [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]

Phrase: "(Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.98: Transfection experiments and luciferase assays Adherent INS-1 cells grown to 8090% confluence in 28-well plates were transfected using Lipofectamine-2000 (Life Technologies, Inc.). 

Phrase: "Transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "luciferase assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "Adherent INS-1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0334154:Adherent [Functional Concept]

Phrase: "grown to 8090% confluence"

Phrase: "in 28-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine-2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312445:lipofectamine 2000 [Organic Chemical]
   861   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.99: Cells were rinsed twice in serum-free culture medium before the addition of the transfection cocktail containing 250 ng reporter plasmid DNA and 500 ng p35 expression plasmid (pCR3-p35). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "twice in serum-free culture medium"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1705217:Medium [Substance]
   753   C1720725:Twice [Intellectual Product]
   753   C1880497:Free [Qualitative Concept]
   753   C1948050:Twice [Quantitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of the transfection cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678420:Cocktail [Food]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "250 ng reporter plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "500 ng p35 expression plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(pCR3-p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.100: Cells were incubated in this mixture for 4 h before adding the normal growth medium and incubating them for an additional 48 h before harvesting for luciferase content assays. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in this mixture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439962:Mixture [Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "the normal growth medium"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   901   C0018270:normal growth [Organism Function]
           'growth' NOS
   901   C0578019:Normal growth [Finding]
   827   C0009458:Medium [Intellectual Product]
   827   C0220844:growth [Physiologic Function]
   827   C0439536:Medium [Quantitative Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C1705217:Medium [Substance]
   827   C2911660:Growth [Activity]
   827   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "them for an additional 48 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Additional [Functional Concept]

Phrase: "before harvesting"

Phrase: "for luciferase content assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.101: Roscovitine treatment was applied 24 h before harvesting the cells at the indicated concentrations. 

Phrase: "Roscovitine treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "24 h before harvesting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "the cells at the indicated concentrations."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0007634:THE CELL [Cell]
           Cells
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.102: Firefly luciferase activity was determined using a luciferase assay kit (Promega Corp., Madison, WI). 

Phrase: "Firefly luciferase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1324397:firefly luciferase activity [Molecular Function]
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a luciferase assay kit (Promega Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0683758:Corp. [Organization]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.103: All experiments were carried out in triplicate on at least three independent occasions. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in triplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "on"

Phrase: "at least three independent occasions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   729   C0521114:Occasional [Temporal Concept]
Processing 00000000.tx.104: Data (emitted light units) are expressed as the mean  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "(emitted light units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "expressed as the mean  SE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.105: Inhibition of p35 expression with siRNA (double-stranded RNA) specific for p35 To specifically inhibit the expression of p35, we used small (21-bp) double-stranded RNAs designed with a sequence complementary to the p35 mRNA. 

Phrase: "Inhibition of p35 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "with siRNA (double-stranded RNA)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0205173:Double [Functional Concept]
   799   C1705764:Double [Activity]
   799   C1705765:Double [Qualitative Concept]
   791   C1979882:Double strand [Qualitative Concept]
   727   C1704972:Strand [Spatial Concept]
   727   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "specific for p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "To specifically"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the expression of p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "(21-bp) double-stranded RNAs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C0035693:RNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205173:Double [Functional Concept]
   804   C1705764:Double [Activity]
   804   C1705765:Double [Qualitative Concept]
   804   C1979882:Double strand [Qualitative Concept]
   733   C1704972:Strand [Spatial Concept]
   733   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "designed with a sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]

Phrase: "complementary to the p35 mRNA."
Processing 00000000.tx.106: These RNAs, also known as siRNA, were synthesized, HPLC-purified, annealed (Dharmacon Research, Inc., Lafayette, CO), and then cotransfected with the insulin promoter luciferase reporter (410 RIP luciferase) and the expression vector for p35. 

Phrase: "These RNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "also"

Phrase: "known as siRNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205309:Known [Qualitative Concept]
   760   C0521102:interfering [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: ","

Phrase: "HPLC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "purified,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "annealed"

Phrase: "(Dharmacon Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Inc.,"

Phrase: "Lafayette,"

Phrase: "CO"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cotransfected with the insulin promoter luciferase reporter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "(410 RIP luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "and"

Phrase: "the expression vector for p35."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.107: The sequence of the sense RNA strand was 5'-GAGGAUCGUGGCGGUGUCATT-3', and that of the antisense sequence was 5'-UGACACCGCCACGAUCCUCTT-3'. 

Phrase: "The sequence of the sense RNA strand"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0162327:RNA Sequence [Nucleotide Sequence]
           Sequence
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "5'-GAGGAUCGUGGCGGUGUCATT-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "that of the antisense sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "5'-UGACACCGCCACGAUCCUCTT-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.108: An additional siRNA with a nonrelated sequence was used as a control. 

Phrase: "An additional siRNA with a nonrelated sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0162327:RNA Sequence [Nucleotide Sequence]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0521102:interfering [Qualitative Concept]
   742   C0700321:Small [Quantitative Concept]

Phrase: "was"

Phrase: "used as a control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.109: To test for the effectiveness of this siRNA, it was cotransfected in the same cells with a Flag-tagged p35 construct, and the corresponding protein was detected by Western blot analysis (see Fig. 5C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for the effectiveness of this siRNA,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0022885:Test [Laboratory Procedure]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
   742   C0521102:interfering [Qualitative Concept]
   742   C0700321:Small [Quantitative Concept]
   742   C1280519:Effectiveness [Qualitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "cotransfected in the same cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0445247:Same [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with a Flag-tagged p35 construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "the corresponding protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by Western blot analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0442726:Detected [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5C"

Phrase: ")."
Processing 00000000.tx.110: The final concentration of dsRNA during transfection was 200 nM, as recommended by the manufacturer. 

Phrase: "The final concentration of dsRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "during transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "200 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "as"

Phrase: "recommended by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034866:Recommended [Idea or Concept]
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.111: The addition of fresh medium after 4 h diluted the RNA interference to 100 nM. 

Phrase: "The addition of fresh medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "after 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "the RNA interference to 100 nM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1136031:RNA Interference [Genetic Function]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0521102:Interference [Qualitative Concept]
Processing 00000000.tx.112: This concentration was maintained for 48 h until cells were harvested. 

Phrase: "This concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "maintained for 48 h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "until cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.113: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.114: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.115: The expression of p35/CDK5 regulates insulin gene expression in insulin-producing -cells. 

Phrase: "The expression of p35/CDK5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "regulates"

Phrase: "insulin gene expression in insulin-producing -cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   757   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.116: A, Western blot performed with the p35 antibody shows that the expression of Flag-tagged p35 in INS-1 cells after transfection is inhibited by siRNA for p35, but not by siRNA complementary to an unrelated target mRNA (control). 

Phrase: "A,"

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "performed with the p35 antibody"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0884358:Performed [Functional Concept]
   760   C3539715:p35 [Gene or Genome]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of Flag-tagged p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "is"

Phrase: "inhibited by siRNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C0521102:interfering [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]

Phrase: "for p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "but"

Phrase: "not by siRNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0521102:interfering [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]
   760   C1518422:Not [Functional Concept]

Phrase: "complementary to an unrelated target mRNA (control"

Phrase: ")."
Processing 00000000.tx.117: Arrows label p35 and Flag-p35 proteins. 

Phrase: "Arrows label p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "Flag-p35 proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.118: The asterisk indicates an unrelated protein detected in INS-1 cells, not affected by siRNAs. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "an unrelated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by siRNAs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   756   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.119: This protein band is not affected by siRNA treatment and therefore may also serve as an equal loading control. 

Phrase: "This protein band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by siRNA treatment"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0392760:Affected [Functional Concept]
   753   C0521102:interfering [Qualitative Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
   719 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "therefore"

Phrase: "may"

Phrase: "also"

Phrase: "serve as an equal loading control."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0205163:Equal [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1708715:Loading [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.120: B, Transfection of p35 up-regulates the expression of a luciferase reporter construct driven by the Rat-1 insulin promoter (410 RIP LUC). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Transfection of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "the expression of a luciferase reporter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "driven by the Rat-1 insulin promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1514732:Rat-1 [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0013126:Drive [Mental Process]

Phrase: "(410 RIP LUC"

Phrase: ")."
Processing 00000000.tx.121: This effect is prevented by siRNA for p35 and roscovitine (10 M), a specific inhibitor of CDK5 kinase activity. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "prevented by siRNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0521102:interfering [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "for p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "roscovitine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]

Phrase: "(10"

Phrase: "M)"

Phrase: ","

Phrase: "a specific inhibitor of CDK5 kinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C3537023:kinase inhibitor activity [Molecular Function]
           kinase inhibitor
   774   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   774   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.122: ***, P < 0.001 vs. control; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.123: ###, P < 0.001 vs. 

Phrase: "###,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.124: p35-transfected values. 

Phrase: "p35-transfected values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.125: C, Cotransfection of the dominant negative CDK5 mutant pCDK5-DN inhibits insulin promoter activity. 

Phrase: "C,"

Phrase: "Cotransfection of the dominant negative CDK5 mutant pCDK5-DN"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin promoter activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1145751:insulin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.126: ***, P <0.001 vs. control cotransfected only with the reporter and p35 vectors.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cotransfected"

Phrase: "only with the reporter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205171:Only [Quantitative Concept]
   770   C0335038:Reporter [Professional or Occupational Group]
   770   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   770   C1705915:Reporter [Conceptual Entity]
   770   C1709908:Reporter [Group]
   770   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "p35 vectors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.127: Statistical methods Data are presented as the mean  SE. 

Phrase: "Statistical methods Data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2828391:statistical data [Quantitative Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   717   C1710191:Statistical Method [Research Activity]

Phrase: "are"

Phrase: "presented as the mean  SE."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0444504:Mean [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.128: The significance of differences in the measured values within and between groups was analyzed using an ANOVA for repeated measures, followed by Fishers t test. 

Phrase: "The significance of differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "in the measured values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "within"

Phrase: "and between groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1515981:And [Idea or Concept]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ANOVA for repeated measures,"

Phrase: "followed by Fishers t test."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   781   C1708064:Fisher's Test [Intellectual Product]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   726   C0325045:Fisher [Mammal]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.129: P < 0.05 was considered statistically significant.  

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.130: Results Top Abstract Introduction Materials and Methods Results Discussion References  Expression of the cell cycle-dependent kinase 5 and its activator p35 in pancreatic islets of Langerhans To assess the expression of CDK-5 and its activator p35 in pancreatic islets of Langerhans, we performed immunofluorescence staining of frozen sections of rat pancreas with specific p35 and CDK5 antibodies. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of the cell cycle-dependent kinase 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its activator p35 in pancreatic islets of Langerhans To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3539715:p35 [Gene or Genome]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the expression of CDK-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its activator p35 in pancreatic islets of Langerhans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3539715:p35 [Gene or Genome]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "immunofluorescence staining of frozen sections of rat pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "with specific p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.131: Positive immunostaining for p35 and CDK5 was observed in the pancreatic islets of Langerhans, but not in other areas of the pancreas (Fig. 1A). 

Phrase: "Positive immunostaining for p35"

Phrase: "and"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "was"

Phrase: "observed in the pancreatic islets of Langerhans,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Pancreatic Islets
           Langerhans Islets
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C1441672:Observed [Functional Concept]

Phrase: "but"

Phrase: "not in other areas of the pancreas"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   748   C0205146:areas [Spatial Concept]
   748   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   748   C1518422:Not [Functional Concept]
   714 E C0017446:Area [Geographic Area]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.132: Both p35 and CDK5 immunostaining colocalized with insulin staining in double-stained sections (Fig. 1A). 

Phrase: "Both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 immunostaining"

Phrase: "colocalized with insulin staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1704680:Staining [Finding]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in double-stained sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.133: The pattern of staining was heterogeneous among different islets. 

Phrase: "The pattern of staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C0449778:Pattern of staining [Spatial Concept]
   770   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "heterogeneous among different islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.134: The larger pancreatic islets showed greater p35 and CDK5 staining intensities compared with the smaller islets. 

Phrase: "The larger pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "greater p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 staining intensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0522510:intensities [Qualitative Concept]

Phrase: "compared with the smaller islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.135: Most of the small islets showed weak or negative staining. 

Phrase: "Most of the small islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205393:Most [Quantitative Concept]
   760   C0700321:Small [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "weak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004093:Weak [Sign or Symptom]
  1000   C1762617:Weak [Qualitative Concept]

Phrase: "or"

Phrase: "negative staining."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0085194:Negative Staining [Laboratory Procedure]
   861   C0205160:Negative [Qualitative Concept]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1513916:Negative [Finding]
   861   C1704680:Staining [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.136: To confirm the presence of p35 and CDK5 in pancreatic islets of Langerhans, we used isolated human islets to investigate the presence of the specific proteins and mRNAs by Western blot analysis and RT-PCR, respectively. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CDK5 in pancreatic islets of Langerhans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1332735:CDK5 [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "isolated human islets to"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the presence of the specific proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mRNAs by Western blot analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "respectively."
Processing 00000000.tx.137: A specific amplified DNA product was obtained by RT-PCR. 

Phrase: "A specific amplified DNA product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "obtained by RT-PCR."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.138: This product showed the predicted size when analyzed by electrophoresis in a 1% agarose gel, and its identity was confirmed by Southern blot analysis (Fig. 1B) and by direct sequencing of the DNA after cloning in a TA pCRII system (data not shown). 

Phrase: "This product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the predicted size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "when"

Phrase: "analyzed by electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "in a 1% agarose gel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1706746:Agarose Gel [Research Device]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "its identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "confirmed by Southern blot analysis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   862   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1710133:Southern [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "and by direct sequencing of the DNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0162326:DNA sequencing [Nucleotide Sequence]
   774   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0439851:Direct [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1553778:Sequencing [Intellectual Product]
   748   C1561491:Sequencing [Functional Concept]
   748   C1947931:Direct [Qualitative Concept]

Phrase: "after cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "in a TA pCRII system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.139: To detect a protein product for p35 and CDK5, isolated human islets of Langerhans were homogenized in buffer A (see Materials and Methods) and equivalent aliquots (200 g protein) of mouse brain (positive control) and liver (negative control) were analyzed by Western blot. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a protein product for p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "CDK5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "isolated human islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: "were"

Phrase: "homogenized in buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "A ("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "equivalent aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "(200 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "of mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by Western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.140: A p35-immunoreactive band was detected in the islet extract that comigrated with a control p35 protein in extract of mouse brain (Fig. 1C). 

Phrase: "A p35-immunoreactive band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "detected in the islet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "comigrated with a control p35 protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3539715:p35 [Gene or Genome]

Phrase: "in extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "of mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.141: This protein was not present in the liver extract that served as a negative control (Fig. 1C). 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the liver extract"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   760   C2828366:Extract [Substance]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "that"

Phrase: "served as a negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.142: After reblotting the membrane with a CDK5 antibody, widespread expression of CDK5 protein was also detected in human islets as well as in brain and liver extracts (Fig. 1C). 

Phrase: "After"

Phrase: "reblotting"

Phrase: "the membrane with a CDK5 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "widespread expression of CDK5 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "detected in human islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "as well as in brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0205170:Well [Qualitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "liver extracts"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023899:Liver Extracts [Organic Chemical,Pharmacologic Substance]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   827   C2828366:Extract [Substance]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.143: View larger version (30K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.145: Expression of p35 and CDK5 in pancreatic islets. 

Phrase: "Expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CDK5 in pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.146: A, Immunocytochemical localization of p35 and CDK5 in insulin-producing -cells of the pancreatic islets of Langerhans. 

Phrase: "A,"

Phrase: "Immunocytochemical localization of p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "CDK5 in insulin-producing -cells of the pancreatic islets of Langerhans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.147: Frozen sections of rat pancreas were double stained with antibodies that recognize p35 (1:500), insulin (1:1000), and cdk5 (1:500). 

Phrase: "Frozen sections of rat pancreas"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0016741:Frozen Sections [Tissue]
   773 E C0085188:Frozen Section [Laboratory Procedure]
   760   C0016701:Frozen [Natural Phenomenon or Process]
   760   C0677542:Frozen [Functional Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "that"

Phrase: "recognize"

Phrase: "p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cdk5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")."
Processing 00000000.tx.148: The antiinsulin fluorochrome is Cy2 (green). 

Phrase: "The antiinsulin fluorochrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "Cy2"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.149: The anti-p35 and CDK5 fluorochrome is Cy3 (red). 

Phrase: "The anti-p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 fluorochrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "Cy3"

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.150: B, RT-PCR amplification of p35 mRNA from human islets and confirmation of its identity by Southern blot. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "RT-PCR amplification of p35 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "from human islets"

Phrase: "and"

Phrase: "confirmation of its identity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   770   C0750484:Confirmation [Idea or Concept]

Phrase: "by Southern blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005862:Southern Blot [Molecular Biology Research Technique]
  1000   C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]
Processing 00000000.tx.151: C, Detection of p35 and CDK5 proteins in human islets and control brain and liver extracts by Western blot analysis. 

Phrase: "C,"

Phrase: "Detection of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CDK5 proteins in human islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1565306:CDK5 protein, human [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "control brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0243148:control [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "liver extracts by Western blot analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023899:Liver Extracts [Organic Chemical,Pharmacologic Substance]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]
   719   C2828366:Extract [Substance]
Processing 00000000.tx.152: After blotting with p35 antibody (1:1000), the filter was directly reblotted with the CDK5 antibody (1:1000). 

Phrase: "After blotting"

Phrase: "with p35 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: ","

Phrase: "the filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]

Phrase: "was"

Phrase: "directly reblotted with the CDK5 antibody"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")."
Processing 00000000.tx.153: D, Detection of p35/CDK5 protein kinase activity in human isolated islets after immunoprecipitation with a p35-specific antibody (see Materials and Methods for more details on the assay). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Detection of p35/CDK5 protein kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2265875:detection of activity [Molecular Function]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in human isolated islets"

Phrase: "after immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with a p35-specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods for more"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "details on the assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]

Phrase: ")."
Processing 00000000.tx.154: Under the conditions of this assay, phosphorylation of histone H1 by p35/CDK5 results in the detection of two isoforms or conformations in sodium dodecyl sulfate denaturing gels. 

Phrase: "Under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of this assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "phosphorylation of histone H1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1156206:histone phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "by p35/CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332735:CDK5 [Gene or Genome]

Phrase: "results in the detection of two isoforms"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205448:Two [Quantitative Concept]
   748   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   748   C1274040:Result [Functional Concept]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "or"

Phrase: "conformations in sodium dodecyl sulfate denaturing gels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.155: This is a common finding throughout the literature. 

Phrase: "This"

Phrase: "is"

Phrase: "a common finding throughout the literature."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]
Processing 00000000.tx.156: Data shown are representative of at least three independent experiments.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.157: Detection of p35/CDK5 protein kinase activity in human islets To determine whether the p35 and CDK5 proteins detected in pancreatic islets interact with one another and form a functional complex, we immunoprecipitated the complex from human islets and determined its protein kinase activity as previously described (16). 

Phrase: "Detection of p35/CDK5 protein kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2265875:detection of activity [Molecular Function]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in human islets To"

Phrase: "determine"

Phrase: "whether"

Phrase: "the p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected in pancreatic islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "interact with one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "another"

Phrase: "and"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a functional complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "we"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "the complex from human islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "determined"

Phrase: "its protein kinase activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1150527:protein kinase activity [Molecular Function]
   981 E C2261495:protein phosphokinase activity [Molecular Function]
   913   C1537044:protein activity [Molecular Function]
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.158: Immunoprecipitation with a p35 antibody, followed by kinase activity determination in the immunoprecipitate using histone H1 as a substrate, demonstrate that p35 and CDK5 form a functional complex capable of phosphorylating histone H1 (Fig. 1D). 

Phrase: "Immunoprecipitation with a p35 antibody,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "followed by kinase activity determination"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C1150423:kinase activity [Molecular Function]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1148554:determination [Laboratory Procedure]
   760   C1561536:*Activity [Idea or Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "in the immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "histone H1 as a substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0019644:Histone H1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "demonstrate"

Phrase: "that p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a functional complex capable of phosphorylating histone H1"

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.159: No kinase activity was detected in the absence of antibody or in the presence of an unrelated control antibody (Fig. 1D). 

Phrase: "No kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected in the absence of antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "or in the presence of an unrelated control antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0243148:control [Qualitative Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0445356:Unrelated [Finding]
   742   C1550141:Control [Substance]
   742   C1704623:Unrelated [Qualitative Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.160: Expression of CDK5 and its activator p35 in -cells correlates with the presence of specific p35/CDK5 kinase activity Additional experiments were designed to investigate the presence of p35, CDK5, and p35/CDK5 kinase activity in -cell lines. 

Phrase: "Expression of CDK5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its activator p35 in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "correlates with the presence of specific p35/CDK5 kinase activity Additional experiments"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   753   C1150423:kinase activity [Molecular Function]
   736   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0205177:Activity [Functional Concept]
   736   C0205369:Specific [Qualitative Concept]
   736   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0392148:Presence [Therapeutic or Preventive Procedure]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C0681814:Experiments [Research Activity]
   736   C1332735:CDK5 [Gene or Genome]
   736   C1524062:Additional [Functional Concept]
   736   C1552740:specific [Intellectual Product]
   736   C1561536:*Activity [Idea or Concept]
   736   C3539715:p35 [Gene or Genome]
   703 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the presence of p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "CDK5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "and"

Phrase: "p35/CDK5 kinase activity in -cell lines."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   818   C0007600:Cell lines [Cell]
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.161: Biochemical characterization of CDK5 kinase activity was also investigated. 

Phrase: "Biochemical characterization of CDK5 kinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "was"

Phrase: "also"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.162: Among the different cell lines tested, only INS-1 cells, an insulin-producing -cell line, showed expression of p35 (Fig. 2A). 

Phrase: "Among the different cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "only INS-1 cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C1414685:INS-1 [Gene or Genome]
   833   C3538717:INS-1 [Gene or Genome]
   770   C0007634:Cells [Cell]
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "an insulin-producing -cell line,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   708   C0030281:Insulin Cell [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.163: These cells also contain protein kinase activity that can be immunoprecipitated with a p35-specific antibody (Fig. 2B). 

Phrase: "These cells also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "protein kinase activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1150527:protein kinase activity [Molecular Function]
   981 E C2261495:protein phosphokinase activity [Molecular Function]
   913   C1537044:protein activity [Molecular Function]
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "immunoprecipitated with a p35-specific antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C3539715:p35 [Gene or Genome]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.164: Both p35 expression and p35/CDK5 activity were absent in other cell lines, such as HeLa and NIH-3T3 (Fig. 2, A and B), although these cell lines expressed CDK5 protein (Fig. 2A). 

Phrase: "Both p35 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "p35/CDK5 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "absent in other cell lines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "such as HeLa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018873:HeLa [Cell]

Phrase: "and"

Phrase: "NIH-3T3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1257739:NIH/3T3 [Cell]
   861   C0027468:NIH [Health Care Related Organization]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "these cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "expressed"

Phrase: "CDK5 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.165: We then investigated whether the kinase activity immunoprecipitated by the p35 antibody was due to its association with CDK5. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "immunoprecipitated by the p35 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3539715:p35 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "was due to its association"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0004083:Association [Mental Process]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1421478:WAS [Gene or Genome]
   760   C3146286:Due [Idea or Concept]

Phrase: "with CDK5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.166: We performed experiments with roscovitine, a relatively specific inhibitor of CDK5 activity (17). 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "experiments with roscovitine,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "a relatively specific inhibitor of CDK5 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.167: The p35/CDK5 activity in INS-1 cells was inhibited by roscovitine, but not by other protein kinase inhibitors, such as H89 (protein kinase A) and SB202190 (p38MAPK; Fig. 2C). 

Phrase: "The p35/CDK5 activity in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "inhibited by roscovitine,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "but"

Phrase: "not by other protein kinase inhibitors,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C2757016:Protein Kinase Inhibitors [Molecular Function]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1152564:Kinase Inhibitors [Molecular Function]
   783 E C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   773 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   773 E C3537023:kinase inhibitor [Molecular Function]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C1518422:Not [Functional Concept]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "such as H89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082782:h89 [Organic Chemical,Pharmacologic Substance]

Phrase: "(protein kinase A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "SB202190"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0291985:SB202190 [Organic Chemical,Pharmacologic Substance]

Phrase: "(p38MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "; Fig. 2C"

Phrase: ")."
Processing 00000000.tx.168: Also, the inhibition by roscovitine was dose dependent (Fig. 2D), with a 50% inhibitory concentration of 128 nM, within the range of that previously reported for CDK5 (18). 

Phrase: "Also,"

Phrase: "the inhibition by roscovitine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "dose dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "with a 50% inhibitory concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   827   C3463820:Inhibitory [Activity]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 128 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "within the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of"

Phrase: "that previously"

Phrase: "reported for CDK5"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1332735:CDK5 [Gene or Genome]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.169: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.170: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.171: Insulin-producing -cells in culture also expressed p35 and CDK5. 

Phrase: "Insulin-producing -cells in culture also expressed p35"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C0007585:cells culture [Laboratory Procedure]
   750   C0030281:Insulin Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CDK5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.172: A, Expression of p35 protein is detected only in INS-1 cells. 

Phrase: "A,"

Phrase: "Expression of p35 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1171362:expression protein [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205171:Only [Quantitative Concept]
   833   C1720467:Only [Intellectual Product]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.173: CDK5 protein is ubiquitously present in different cell lines. 

Phrase: "CDK5 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "ubiquitously"

Phrase: "present in different cell lines."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0150312:Present [Quantitative Concept]
   760   C0205132:lines [Spatial Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705242:Different [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.174: B, p35/CDK5 kinase activity is detected specifically in insulin-producing -cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "p35/CDK5 kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "specifically in insulin-producing -cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   781   C0030281:Insulin Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.175: C, Kinase activity after immunoprecipitation with p35 antibody in INS-1 cells is inhibited by the CDK5-specific inhibitor roscovitine. 

Phrase: "C,"

Phrase: "Kinase activity after immunoprecipitation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1150423:kinase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "with p35 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "inhibited by the CDK5-specific inhibitor roscovitine."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205369:Specific [Qualitative Concept]
   748   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]
   748   C1332735:CDK5 [Gene or Genome]
   748   C1552740:specific [Intellectual Product]
   748   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.176: D, Roscovitine inhibition is dose dependent, with kinetics values equivalent to those previously reported for CDK5. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Roscovitine inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "dose dependent,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "with kinetics values equivalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205163:Equivalent [Qualitative Concept]
   827   C0439185:equivalent [Quantitative Concept]

Phrase: "to those previously"

Phrase: "reported for CDK5."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1332735:CDK5 [Gene or Genome]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.177: Data shown are representative of at least three independent experiments.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.178: Immunoprecipitation experiments with cellular extracts from INS-1 cells demonstrate that the endogenous complex with kinase activity contains both p35 and CDK5 proteins The p35/CDK5 protein kinase data described to date was obtained using a method described for brain extracts, with the assumption that in -cells both p35 and CDK5 exist in a complex such as occurs in the brain (19). 

Phrase: "Immunoprecipitation experiments with cellular extracts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "from"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the endogenous complex with kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "The p35/CDK5 protein kinase data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]
   717   C0249586:Cdk5 Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "described to date"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C1552738:described [Idea or Concept]
   790   C2348077:Date [Food]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "described for brain extracts,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1552738:described [Idea or Concept]
   737   C2828366:Extract [Substance]

Phrase: "with the assumption"

Phrase: "that in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "exist in a complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "such as"

Phrase: "occurs in the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.179: The kinase assay is performed after immunoprecipitation of the complex with a p35 antibody (19). 

Phrase: "The kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "performed after immunoprecipitation of the complex"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0021069:Immunoprecipitation [Laboratory Procedure]
   753   C0439855:Complex [Qualitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with a p35 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.180: We therefore investigated whether the kinase activity detected in -cells could be immunoprecipitated with a CDK5 antibody. 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "immunoprecipitated with a CDK5 antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1332735:CDK5 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.181: Our findings indicate that both p35 and CDK5 antibodies are capable of immunoprecipitating p35/CDK5-associated activity in INS-1 cells (Fig. 3A). 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "capable of immunoprecipitating p35/CDK5-associated activity"

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.182: An immunoprecipitate obtained with an antibody reactive toward an unrelated protein (control) did not show kinase activity. 

Phrase: "An immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "obtained with an antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "reactive toward an unrelated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205332:Reactive [Qualitative Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "kinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.183: The activity detected with the CDK5 antibody was weaker than that obtained with an equivalent amount of p35 antibody in both INS-1 cells and brain extracts. 

Phrase: "The activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "detected with the CDK5 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0442726:Detected [Finding]
   760   C1332735:CDK5 [Gene or Genome]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "weaker than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0004093:Weak [Sign or Symptom]
   756   C1762617:Weak [Qualitative Concept]

Phrase: "obtained with an equivalent amount of p35 antibody"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205163:Equivalent [Qualitative Concept]
   744   C0439185:equivalent [Quantitative Concept]
   744   C1265611:Amount [Quantitative Concept]
   744   C1301820:Obtained [Functional Concept]
   744   C3539715:p35 [Gene or Genome]
   711 E C1706701:Obtain [Activity]

Phrase: "in both INS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1414685:INS-1 [Gene or Genome]
   734   C3538717:INS-1 [Gene or Genome]

Phrase: "and"

Phrase: "brain extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.184: As both p35 and CDK5 antibodies were equally active in extracts from INS-1 and mouse brain, we considered several possibilities to explain the differences between the two antibodies. 

Phrase: "As"

Phrase: "both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "equally active in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "from"

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "mouse brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "several possibilities to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   743   C0332149:Possible [Qualitative Concept]
   743   C1705910:Possible [Qualitative Concept]
   743   C2362652:Possible [Qualitative Concept]

Phrase: "explain"

Phrase: "the differences between the two antibodies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.185: First, the CDK5 antibody may have a lower affinity for its protein target. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the CDK5 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "may"

Phrase: "have"

Phrase: "a lower affinity for its protein target."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.186: Second, CDK5 antibody binding to the p35/CDK5 complex may partially interfere with the functional activity of the complex. 

Phrase: "Second, CDK5 antibody binding to the p35/CDK5 complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "may"

Phrase: "partially"

Phrase: "interfere with the functional activity of the complex."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0205177:Activity [Functional Concept]
   744   C0205245:Functional [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0441655:Activity [Activity]
   744   C0521102:Interfere [Qualitative Concept]
   744   C0542341:Functional [Functional Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.187: Finally, as CDK5 protein is in excess with respect to p35, active p35/CDK5 complexes not only may be immunoprecipitated by the CDK5 antibody, but also may uncouple CDK5 without kinase activity. 

Phrase: "Finally,"

Phrase: "as"

Phrase: "CDK5 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is in excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1979886:Excess [Qualitative Concept]

Phrase: "with respect to p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "active p35/CDK5 complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "immunoprecipitated by the CDK5 antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1332735:CDK5 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "but"

Phrase: "also"

Phrase: "may"

Phrase: "uncouple"

Phrase: "CDK5 without kinase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.188: To provide further evidence that the immunoprecipitated kinase activity depends on the presence of CDK5 we performed Western blots with the CDK5 antibody on the immunoprecipitated material. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the immunoprecipitated kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "depends on the presence of CDK5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0725813:depend [Medical Device]
   753   C1332735:CDK5 [Gene or Genome]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Western blots with the CDK5 antibody"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0949466:Western Blots [Laboratory Procedure]
   756 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1705493:Western [Spatial Concept]

Phrase: "on the immunoprecipitated material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.189: Results from these experiments clearly indicated p35 and CDK5 associate in INS1 cells, resulting in the formation of a functionally active kinase complex (Fig. 3B). 

Phrase: "Results from these experiments clearly indicated p35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   716   C2825142:Experimental Result [Finding]
           Result
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]

Phrase: "and"

Phrase: "CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "associate in INS1 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "resulting in the formation of a functionally active kinase complex"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0332294:Resulting in [Functional Concept]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205177:Active [Functional Concept]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C0439855:Complex [Qualitative Concept]
   739   C0678226:resulting [Functional Concept]
   739   C1522492:Formation [Functional Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]
   706 E C1274040:Result [Functional Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C2825142:Result [Finding]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.190: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.192: Expression of endogenous p35 and CDK5 proteins and forced p35 expression by transfection in INS-1 cells reconstitute functional p35/CDK5 complexes with kinase activity. 

Phrase: "Expression of endogenous p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CDK5 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "forced p35 expression by transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "reconstitute"

Phrase: "functional p35/CDK5 complexes with kinase activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.193: A, Functional kinase complexes are immunoprecipitated from INS-1 cells with both p35 and CDK5 antibodies and with equivalent affinities to those obtained with brain extracts. 

Phrase: "A,"

Phrase: "Functional kinase complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "are"

Phrase: "immunoprecipitated from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and with equivalent affinities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205163:Equivalent [Qualitative Concept]
   770   C0439185:equivalent [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   737   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "to those"

Phrase: "obtained with brain extracts."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
   737   C2828366:Extract [Substance]
Processing 00000000.tx.194: B, Top, Western blot analysis with the CDK5 antibody in the immunoprecipitates performed with the p35 antibody demonstrates coprecipitation of p35 and CDK5 in both INS1 cells and brain extracts. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "Western blot analysis with the CDK5 antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "in the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "performed with the p35 antibody"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0884358:Performed [Functional Concept]
   760   C3539715:p35 [Gene or Genome]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "demonstrates"

Phrase: "coprecipitation of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0301915:Coprecipitation [Molecular Function]

Phrase: "and"

Phrase: "CDK5 in both INS1 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1332735:CDK5 [Gene or Genome]

Phrase: "and"

Phrase: "brain extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.195: A control extract from mouse brain was directly run for size comparison. 

Phrase: "A control extract from mouse brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "run for size comparison."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0035953:run [Daily or Recreational Activity]
   770   C0456389:size [Spatial Concept]
   770   C0600140:run [Finding]
   770   C1704688:Run [Functional Concept]
   770   C1707455:Comparison [Activity]
   770   C2346414:Run [Finding]
Processing 00000000.tx.196: Bottom, The same filter was reblotted with the p35 antibody to demonstrate its presence in the immunoprecipitates. 

Phrase: "Bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "The same filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0180860:Filter [Manufactured Object]
   861   C0581406:Filter [Medical Device]
   861   C1522664:Filter [Intellectual Product]
   861   C1704449:Filter [Conceptual Entity]
   861   C1704684:Filter [Medical Device]
   861   C1875155:FILTER [Medical Device]

Phrase: "was"

Phrase: "reblotted with the p35 antibody to"

Phrase: "demonstrate"

Phrase: "its presence in the immunoprecipitates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.197: C, Western blot analysis with the p35 antibody showing the expression of the p35 and Flag-tagged p35 vectors. 

Phrase: "C,"

Phrase: "Western blot analysis with the p35 antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the expression of the p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Flag-tagged p35 vectors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.198: The corresponding expression vectors were transfected in COS-1 cells and analyzed 48 h later. 

Phrase: "The corresponding expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vectors [Spatial Concept]
   793 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "transfected in COS-1 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "48 h later."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.199: Asterisks indicate nonspecific bands unchanged by transfection. 

Phrase: "Asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "nonspecific bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "unchanged by transfection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.200: D, p35/CDK5 kinase activity was detected after immunoprecipitation with a Flag antibody in INS-1 cells that had been previously transfected with the pCMV-Flag-p35 vector. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "p35/CDK5 kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected after immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with a Flag antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "previously"

Phrase: "transfected with the pCMV-Flag-p35 vector."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1708067:Flag [Functional Concept]
   748   C3539715:p35 [Gene or Genome]
Processing 00000000.tx.201: No activity was detected in cells transfected with the control empty vector.  

Phrase: "No activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected in cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the control empty vector."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0031249:control vector [Occupational Activity]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.202: Forced expression of p35 by transfection reconstitutes an active kinase complex by associating with endogenous CDK5 To investigate further the functional role of p35/CDK5 signaling in insulin-producing -cells, we prepared expression vectors for p35 and Flag-tagged p35 by cDNA cloning using RNA from INS-1 cells. 

Phrase: "Forced expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "reconstitutes"

Phrase: "an active kinase complex by associating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with endogenous CDK5 To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1332735:CDK5 [Gene or Genome]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the functional role of p35/CDK5 signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1705810:Functional Role [Conceptual Entity]
           Role
   748   C0035820:Role [Social Behavior]

Phrase: "in insulin-producing -cells,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "expression vectors for p35"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "Flag-tagged p35 by cDNA cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3539715:p35 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RNA from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.203: These vectors were sequenced and tested for protein expression in COS-1 cells (Fig. 3C). 

Phrase: "These vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "tested for protein expression"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1171362:protein expression [Genetic Function]
   802   C0788300:PROTEIN TEST [Medical Device]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "in COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.204: We then evaluated the capacity of this expression vector to reconstitute an active functional p35/CDK5 kinase complex in INS-1 cells. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the capacity of this expression vector to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "reconstitute"

Phrase: "an active functional p35/CDK5 kinase complex in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.205: As INS-1 cells already have endogenous p35/CDK5 activity, we used the expression vector coding for a p35 protein tagged with a Flag sequence and immunoprecipitated cellular extracts 48 h after transfection. 

Phrase: "As"

Phrase: "INS-1 cells already"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "endogenous p35/CDK5 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the expression vector coding for a p35 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0009219:Coding [Occupational Activity]

Phrase: "tagged with a Flag sequence"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708067:Flag [Functional Concept]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "immunoprecipitated cellular extracts 48 h after transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.206: Specific protein kinase activity was detected after immunoprecipitation with a specific Flag antibody, but not by using an unrelated control antibody (Fig. 3D). 

Phrase: "Specific protein kinase activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected after immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with a specific Flag antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "but"

Phrase: "not by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an unrelated control antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.207: The concentration of glucose in the culture medium regulates p35 expression and p35/CDK5 kinase activity in INS-1 cells We next investigated whether the expression of the CDK5 activator p35 in -cells may itself be regulated by glucose. 

Phrase: "The concentration of glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0427743:Glucose concentration [Laboratory Procedure]
   819   C1287281:Glucose concentration [Laboratory or Test Result]
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "regulates"

Phrase: "p35 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "p35/CDK5 kinase activity in"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the expression of the CDK5 activator p35 in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "itself"

Phrase: "be"

Phrase: "regulated by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.208: Our results indicate that the level of p35 mRNA in -cells is stimulated by the extracellular concentration of glucose. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the level of p35 mRNA in -cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "stimulated by the extracellular concentration of glucose."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0427743:Glucose concentration [Laboratory Procedure]
   774   C1287281:Glucose concentration [Laboratory or Test Result]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0086045:Concentration [Mental Process]
   748   C0521119:Extracellular [Cell Component]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.209: RT-PCR experiments show a progressive increase in the p35 mRNA content of INS-1 cells when they are exposed for 24 h to increasing concentrations of glucose in the culture medium (Fig. 4A). 

Phrase: "RT-PCR experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a progressive increase in the p35 mRNA content of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "they"

Phrase: "are"

Phrase: "exposed for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332157:Exposed [Clinical Attribute]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "to increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.210: The increase in p35 mRNA levels is specific, because no changes were observed in the levels of -actin mRNA, which served as a control (Fig. 4A). 

Phrase: "The increase in p35 mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "no changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in the levels of -actin mRNA,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   748   C1441672:Observed [Functional Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "served as a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.211: The increase in p35 mRNA is translated into a corresponding increase in the levels of p35 protein as assessed by Western blot assays (Fig. 4B). 

Phrase: "The increase in p35 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "translated into a corresponding increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040710:translated [Occupational Activity]
   760   C0442805:Increase [Functional Concept]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of p35 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "assessed by Western blot assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C0949466:Western blot assay [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1516048:Assessed [Activity]
   760   C1705493:Western [Spatial Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: No changes in the levels of CDK5 protein were observed in these experiments (Fig. 4B), indicating that the CDK5 regulatory subunit p35, and not the CDK5 protein itself, is regulated by glucose. 

Phrase: "No changes in the levels of CDK5 protein"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   754   C0442739:No change [Finding]
   754   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in these experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1441672:Observed [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the CDK5 regulatory subunit p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the CDK5 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself,"

Phrase: "is"

Phrase: "regulated by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.213: To determine whether the increase in p35 resulted in a functional elevation of p35/CDK5 kinase activity, we performed immunoprecipitation and kinase assays. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the increase in p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "resulted in a functional elevation of p35/CDK5 kinase activity,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C1150423:kinase activity [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205177:Activity [Functional Concept]
   739   C0205245:Functional [Functional Concept]
   739   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0439167:% activity [Quantitative Concept]
   739   C0439775:Elevation [Therapeutic or Preventive Procedure]
   739   C0441655:Activity [Activity]
   739   C0542341:Functional [Functional Concept]
   739   C0702240:Elevation [Spatial Concept]
   739   C1332735:CDK5 [Gene or Genome]
   739   C1561536:*Activity [Idea or Concept]
   739   C2700217:Functional [Conceptual Entity]
   739   C3539715:p35 [Gene or Genome]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "kinase assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.214: The results of these experiments show a corresponding elevation of p35/CDK5 activity when the extracellular concentration of glucose was increased from 5 to 20 mM at different time points ranging from 224 h (Fig. 4C). 

Phrase: "The results of these experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a corresponding elevation of p35/CDK5 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "when"

Phrase: "the extracellular concentration of glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0427743:Glucose concentration [Laboratory Procedure]
   797   C1287281:Glucose concentration [Laboratory or Test Result]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "increased from 5"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to 20 mM"

Phrase: "at different time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "ranging from 224 h (Fig. 4C"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0349966:Fig [Food]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0450376:4c [Intellectual Product]
   753   C0564385:/h [Quantitative Concept]
   753   C1337208:FIG [Food]
   719   C1514721:Range [Quantitative Concept]
   719   C2348147:Range [Quantitative Concept]
   719   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: The time-dependent induction in p35/CDK5 kinase activity started between 1 and 2 h after glucose stimulation (Fig. 4D). 

Phrase: "The time-dependent induction in p35/CDK5 kinase activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1621983:induction activity [Cell Function]
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "started between 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1272689:Started [Qualitative Concept]
   756 E C0439659:Start [Temporal Concept]

Phrase: "and"

Phrase: "2 h after glucose stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.216: View larger version (33K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.217: 4. 

Phrase: "4."
Processing 00000000.tx.218: Glucose concentration regulates p35 expression and increases p35/CDK5 kinase activity in INS-1 cells. 

Phrase: "Glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "regulates"

Phrase: "p35 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "p35/CDK5 kinase activity in"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.219: A, Expression of p35 mRNA was detected by RT-PCR and was confirmed by Southern blot analysis using an internal oligonucleotide probe. 

Phrase: "A,"

Phrase: "Expression of p35 mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1515670:mRNA Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected by RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0442726:Detected [Finding]
   770   C0677874:pCR [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "was"

Phrase: "confirmed by Southern blot analysis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   862   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1710133:Southern [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an internal oligonucleotide probe."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.220: Actin mRNA expression served as a control. 

Phrase: "Actin mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "served as a control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.221: INS-1 cells were maintained at the indicated concentrations of glucose (Glu) for 24 h before harvesting and isolation of total RNA. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained at the indicated concentrations of glucose (Glu)"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   774   C0427743:concentrations glucose [Laboratory Procedure]
   774   C1287281:concentrations glucose [Laboratory or Test Result]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C1314677:Maintained [Functional Concept]
   748   C1444656:Indicated [Finding]
   714 E C0024501:Maintain [Activity]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before harvesting"

Phrase: "and"

Phrase: "isolation of total RNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]
Processing 00000000.tx.222: B, Western blot analysis detects p35 and CDK5 proteins in experiments performed in INS-1 cells cultured at different glucose (Glu) concentrations for 24 h. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "CDK5 proteins in experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0249586:Cdk5 Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "performed in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured at different glucose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1705242:Different [Qualitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(Glu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "concentrations for 24 h."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0020283:H+ concentration [Quantitative Concept]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.223: C, Time-dependent stimulation of p35/CDK5 activity in INS-1 cells exposed to high glucose (20 mM) or maintained in normoglycemic conditions (5 mM) for the corresponding periods of time. 

Phrase: "C,"

Phrase: "Time-dependent stimulation of p35/CDK5 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to high glucose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C0860803:high glucose [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "(20 mM)"

Phrase: "or"

Phrase: "maintained in normoglycemic conditions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0580545:Normoglycaemic [Finding]
   770   C1314677:Maintained [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737 E C0024501:Maintain [Activity]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "(5 mM) for the corresponding periods of time."
Processing 00000000.tx.224: D, Induction of p35/CDK5 activity by glucose stimulation occurs between 1 and 2 h after glucose stimulation. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Induction of p35/CDK5 activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1621983:induction activity [Cell Function]
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by glucose stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "occurs between 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "2 h after glucose stimulation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.225: Densitometric quantification of the data is shown in the bottom panel. 

Phrase: "Densitometric quantification of the data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "is"

Phrase: "shown in the bottom panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Panel [Idea or Concept]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.226: The data shown are representative of at least three independent experiments with very consistent outcomes.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "with very consistent outcomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.227: Signaling through p35/CDK5 results in transcriptional activation of the insulin gene Next we examined whether p35/CDK5 signaling is involved in the regulation of insulin gene expression. 

Phrase: "Signaling through p35/CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "results in transcriptional activation of the insulin gene Next"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0162493:Transcriptional Activation [Genetic Function]
   764   C1337112:Insulin Gene [Gene or Genome]
   762   C0017255:Gene Activation [Genetic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   742   C0205117:next [Spatial Concept]
   742   C0332282:Next [Temporal Concept]
   742   C1274040:Result [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1546471:Result [Idea or Concept]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1879547:Activation [Activity]
   742   C1883708:Next [Temporal Concept]
   742   C2825142:Result [Finding]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "p35/CDK5 signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "involved in the regulation of insulin gene expression."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   819   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   770   C0017262:Gene Expression [Genetic Function]
   770   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.228: We performed cotransfection experiments in insulin-producing -cells (INS-1) in which p35, and therefore p35/CDK5, activity was raised by artificially transfecting an expression vector for p35. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cotransfection experiments in insulin-producing -cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in which p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "therefore p35/CDK5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1332735:CDK5 [Gene or Genome]

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "raised by artificially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442818:Raised [Quantitative Concept]

Phrase: "transfecting"

Phrase: "an expression vector for p35."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.229: The expression of p35 was also decreased by the use of specific siRNAs for p35. 

Phrase: "The expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "decreased by the use of specific siRNAs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0457083:Use [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1947944:Use [Intellectual Product]
   714 E C0547047:Decrease [Quantitative Concept]
   714   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for p35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]
Processing 00000000.tx.230: siRNA have become a new tool for specifically inhibiting the expression of a particular gene. 

Phrase: "siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "have"

Phrase: "become"

Phrase: "a new tool for specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0336791:Tool [Manufactured Object]
   760   C2827396:Tool [Manufactured Object]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the expression of a particular gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.231: siRNAs catalyze the degradation of the mRNA to which the siRNA sequence is complementary. 

Phrase: "siRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the degradation of the mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1257759:mRNA Degradation [Genetic Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "to which"

Phrase: "the siRNA sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0162327:RNA Sequence [Nucleotide Sequence]
           Sequence
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   756   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "complementary."
Processing 00000000.tx.232: The cotransfection of siRNA for p35 (200 nM) not only prevents the expression of a Flag-tagged p35 protein in INS-1 cells, but also decreases the endogenous p35 (Fig. 5A) without affecting the expression of other proteins not targeted by the siRNA. 

Phrase: "The cotransfection of siRNA"

Phrase: "for p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "(200 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the expression of a Flag-tagged p35 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "also"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the endogenous p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "without affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the expression of other proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "targeted by the siRNA."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0521102:interfering [Qualitative Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C1521840:Targeted [Functional Concept]
   719 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.233: The effect of p35-siRNA in the suppression of endogenous p35 was less effective. 

Phrase: "The effect of p35-siRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in the suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of endogenous p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "was"

Phrase: "less effective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:effective [Qualitative Concept]
   861   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.234: siRNA needs to enter the cells via transfection, and the efficiency of transfection in these experiments was approximately 20%. 

Phrase: "siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the cells via transfection,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0007634:THE CELL [Cell]
           Cells
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the efficiency of transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:Efficiency [Quantitative Concept]

Phrase: "in these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "approximately 20%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]
Processing 00000000.tx.235: The cotransfection of an expression vector for p35 with a luciferase reporter under the control of the insulin gene promoter results in a 3-fold activation of transcription (Fig. 5B). 

Phrase: "The cotransfection of an expression vector"

Phrase: "for p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "with a luciferase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0335038:Reporter [Professional or Occupational Group]
   861   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   861   C1705915:Reporter [Conceptual Entity]
   861   C1709908:Reporter [Group]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the insulin gene promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "results in a 3-fold activation of transcription"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0162493:Transcription Activation [Genetic Function]
   744   C0040649:Transcription [Genetic Function]
   744   C0332462:Fold [Spatial Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1879547:Activation [Activity]
   744   C1880834:FOLD [Phenomenon or Process]
   744   C2825142:Result [Finding]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.236: Activation of the insulin promoter by p35 was significantly inhibited by cotransfection of a specific p35 siRNA as well as by the administration of roscovitine (10 M), a CDK5-specific inhibitor (Fig. 5B). 

Phrase: "Activation of the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "was"

Phrase: "significantly"

Phrase: "inhibited by cotransfection of a specific p35 siRNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205369:Specific [Qualitative Concept]
   739   C0311403:Inhibited [Qualitative Concept]
   739   C0521102:interfering [Qualitative Concept]
   739   C0700321:Small [Quantitative Concept]
   739   C1552740:specific [Intellectual Product]
   739   C3539715:p35 [Gene or Genome]

Phrase: "as well as by the administration of roscovitine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0001554:Administration [Occupational Activity]
   744   C0205170:Well [Qualitative Concept]
   744   C0536217:roscovitine [Organic Chemical,Pharmacologic Substance]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]
   744   C3146287:Well [Manufactured Object]

Phrase: "(10"

Phrase: "M)"

Phrase: ","

Phrase: "a CDK5-specific inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.237: Similar results were obtained in several preliminary experiments when the efficiency of transfection was corrected by cotransfecting an expression vector for Renilla luciferase (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in several preliminary experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0439611:Preliminary [Temporal Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "when"

Phrase: "the efficiency of transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:Efficiency [Quantitative Concept]

Phrase: "was"

Phrase: "corrected by cotransfecting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205202:Corrected [Qualitative Concept]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "an expression vector for Renilla luciferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.238: In these experiments no effect on luciferase activity was detected when an unrelated siRNA control was used. 

Phrase: "In these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "no effect on luciferase activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "an unrelated siRNA control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   717   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.239: In addition, a dominant negative mutant of CDK5 (CDK5-DN) containing a point mutation that affects its active site (15) inhibited p35-stimulated insulin promoter activity (Fig. 5C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a dominant negative mutant of CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(CDK5-DN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "p35-stimulated insulin promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1145751:insulin activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.240: These observations indicate that the activation of the insulin promoter by p35 is specific and is a result of the formation of a functional p35/CDK5 complex with protein kinase activity.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the activation of the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "by p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "is"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "a result of the formation of a functional p35/CDK5 complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]

Phrase: "with protein kinase activity."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1150527:protein kinase activity [Molecular Function]
   981 E C2261495:protein phosphokinase activity [Molecular Function]
   913   C1537044:protein activity [Molecular Function]
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.241: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Here we report the expression of p35, an activator of CDK5, in insulin-producing pancreatic endocrine -cells. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the expression of p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "an activator of CDK5,"

Phrase: "in insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "producing"

Phrase: "pancreatic endocrine -cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0229525:Endocrine Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014136:Endocrine [Body System]
   827   C0521425:Endocrine [Functional Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.242: We also confirm the expression of CDK5 in -cells and the formation of a functional p35/CDK5 complex with specific protein kinase activity. 

Phrase: "We also"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the expression of CDK5 in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the formation of a functional p35/CDK5 complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "with specific protein kinase activity."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.243: Similar to other members of the cyclin-dependent kinase family, CDK5 protein-kinase activity is dependent on its association with activators. 

Phrase: "Similar to other members of the cyclin-dependent kinase family,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "CDK5 protein-kinase activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0249586:Cdk5 Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "dependent on its association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "with activators."
Processing 00000000.tx.244: CDK activators are known as cyclins. 

Phrase: "CDK activators"

Phrase: "are"

Phrase: "known as cyclins."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0079183:Cyclins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205309:Known [Qualitative Concept]
   756 E C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1150565:cyclin [Molecular Function]
Processing 00000000.tx.245: However, in the case of CDK5, its activator p35 does not belong to the cyclin family, although both p35 and cyclins acquire an equivalent three-dimensional conformation that allows them to interact and activate CDKs (20, 21). 

Phrase: "However,"

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of CDK5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "its activator p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "belong to the cyclin family,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015576:Family [Family Group]
   760   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1150565:cyclin [Molecular Function]
   760   C1704727:Family [Conceptual Entity]

Phrase: "although"

Phrase: "both p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "cyclins"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0079183:Cyclins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1150565:cyclin [Molecular Function]

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "an equivalent three-dimensional conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0026377:Conformation [Spatial Concept]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "them to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "CDKs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0243045:CDK [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1150557:CDK [Molecular Function]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.246: Initially, the expression of p35 was believed to be restricted to the central nervous system, the lens (22), and recently in developing muscle, where it forms a p35/CDK5 active complex that regulates the expression of the acetylcholine receptor gene (23). 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "the expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "restricted to the central nervous system,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0443288:Restricted [Functional Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "the lens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023317:Lens [Body Part, Organ, or Organ Component]
  1000   C0023318:Lens [Medical Device]
  1000   C0996842:Lens [Plant]
  1000   C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "recently in developing muscle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026845:Muscle [Tissue]
   770   C0332185:Recently [Temporal Concept]

Phrase: "where"

Phrase: "it"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a p35/CDK5 active complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "regulates"

Phrase: "the expression of the acetylcholine receptor gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0017262:Gene Expression [Genetic Function]
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.247: Despite its name CDK5 does not affect the cell division cycle; 

Phrase: "Despite its name CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332735:CDK5 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the cell division cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007586:Cell Division Cycle [Cell Function]
           Cell Cycle
   913   C1155839:Cell Cycle [Cell Function]
   827   C1511572:Cycle [Temporal Concept]
   734   C0007590:Cell division [Cell Function]

Phrase: ";"
Processing 00000000.tx.248: it is expressed postmitotically, and its function is related to cytoskeletal dynamics, cell migration, cell differentiation, and exocytosis (14) instead of cellular proliferation. 

Phrase: "it"

Phrase: "is"

Phrase: "expressed"

Phrase: "postmitotically,"

Phrase: "and"

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "related to cytoskeletal dynamics,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0010853:Cytoskeletal [Cell Component]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "cell migration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "cell differentiation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "(14"

Phrase: ")"

Phrase: "instead of cellular proliferation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.249: Recently, Pho-85, a yeast ortholog of CDK5, was shown to be involved in metabolic control by regulating different steps of glycogen and phosphate metabolism (13). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Pho-85,"

Phrase: "a yeast ortholog of CDK5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1335144:Ortholog [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in metabolic control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1513158:Metabolic Control [Molecular Function]
   770   C0243148:control [Qualitative Concept]
   770   C0311400:Metabolic [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1524026:Metabolic [Cell Function]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2707259:Metabolic [Clinical Attribute]
   770   C3274648:Control [Qualitative Concept]

Phrase: "by"

Phrase: "regulating"

Phrase: "different steps of glycogen"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1261552:steps [Conceptual Entity]
   737 E C1704379:Step [Functional Concept]
   737 E C1705117:Step [Quantitative Concept]
   737 E C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "phosphate metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158883:phosphate metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.250: Expression of CDK5 in insulin-producing cells is not surprising because widespread expression of this kinase has been described. 

Phrase: "Expression of CDK5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in insulin-producing cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "because"

Phrase: "widespread expression of this kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.251: CDK5 expression in -cells has also been reported (24). 

Phrase: "CDK5 expression in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.252: Our findings demonstrate the expression of p35, the activator of CDK5, in insulin-producing -cells. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "the expression of p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the activator of CDK5,"

Phrase: "in insulin-producing -cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.253: Expression of p35 in the pancreas was not detected earlier in Northern blot testing for tissue-specific expression (19), probably due to the fact that only a small fraction of the total pancreas RNA is derived from islets. 

Phrase: "Expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "earlier in Northern blot testing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0005861:Northern Blot [Molecular Biology Research Technique]
   806   C1621557:Northern Blot [Research Device]
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   760   C1709269:Northern [Spatial Concept]
   726   C1279919:Early [Temporal Concept]

Phrase: "for tissue-specific expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1955394:Tissue specific [Body Substance]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "probably due to the fact"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0750492:Probably [Idea or Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small fraction of the total pancreas RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0439160:Fraction of total [Quantitative Concept]
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "derived from islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]
Processing 00000000.tx.254: Also, the expression of p35 at a normal physiological concentration of glucose is very low in -cells, its maximal expression is only achieved after glucose stimulation. 

Phrase: "Also,"

Phrase: "the expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at a normal physiological concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1277200:Normal concentration [Finding]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "very low in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "its maximal expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "achieved after glucose stimulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.255: Our data also confirm the expression of CDK5 in -cells and demonstrate the existence of a functional p35/CDK5 protein kinase pathway in insulin-producing -cells. 

Phrase: "Our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the expression of CDK5 in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "demonstrate"

Phrase: "the existence of a functional p35/CDK5 protein kinase pathway"

Phrase: "in insulin-producing -cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.256: Perhaps the most important finding in these studies is the fact that the expression of p35 and the protein kinase activity of the p35/CDK5 complex in -cells are tightly regulated by changes in the extracellular concentration of glucose. 

Phrase: "Perhaps"

Phrase: "the most important finding in these studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "the fact"

Phrase: "that"

Phrase: "the expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the protein kinase activity of the p35/CDK5 complex in -cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   775   C1150527:protein kinase activity [Molecular Function]
   757 E C2261495:protein phosphokinase activity [Molecular Function]
   756   C1150423:kinase activity [Molecular Function]
   754   C1537044:protein activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "tightly"

Phrase: "regulated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the extracellular concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.257: It is known that the expression of genes essential for the function of -cells, such as insulin, PDX-1 (pancreatic and duodenal homeobox-1), amylin, and glucose transporter 2, are closely regulated by extracellular concentrations of glucose. 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "essential for the function of -cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "such as insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "(pancreatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "duodenal homeobox-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   827   C0242303:Homeo Box [Gene or Genome]
   827   C0598306:Homeo Box [Spatial Concept]
   755 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "glucose transporter 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "closely"

Phrase: "regulated by extracellular concentrations of glucose."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0427743:concentrations glucose [Laboratory Procedure]
   783   C1287281:concentrations glucose [Laboratory or Test Result]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0521119:Extracellular [Cell Component]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   719 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.258: This circumstance suggests that the p35/CDK5 protein kinase pathway may play an important role in -cell function. 

Phrase: "This circumstance"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the p35/CDK5 protein kinase pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C0249586:Cdk5 Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in -cell function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0007613:Cell Function [Cell Function]
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1705273:Function [Intellectual Product]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.259: In fact, our initial functional studies indicate that p35/CDK5 is involved in the expression of the insulin gene. 

Phrase: "In fact,"

Phrase: "our initial functional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that p35/CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332735:CDK5 [Gene or Genome]

Phrase: "is"

Phrase: "involved in the expression of the insulin gene."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1337112:Insulin Gene [Gene or Genome]
   767   C0017262:Gene Expression [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C1314939:Involved [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.260: Our data show that overexpression of p35 results in an increased activity of the insulin promoter in INS-1 cells, and that inhibition of the p35/CDK5 activity using several strategies, such as specific siRNA for p35; 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that overexpression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "results in an increased activity of the insulin promoter"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0474395:increased activity [Finding]
   762   C0020459:increased insulin [Disease or Syndrome]
   762   C1145751:insulin activity [Molecular Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205177:Activity [Functional Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0442805:Increased [Functional Concept]
   742   C1274040:Result [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1546471:Result [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2825142:Result [Finding]

Phrase: "in"

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that inhibition of the p35/CDK5 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several strategies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "such as specific siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0521102:interfering [Qualitative Concept]
   812   C0700321:Small [Quantitative Concept]

Phrase: "for p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.261: the use of roscovitine, a relatively specific CDK5 inhibitor (17); 

Phrase: "the use of roscovitine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "a relatively specific CDK5 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.262: and cotransfection of a dominant negative mutant form of CDK5 (15), decreases the activation of the insulin promoter induced by p35. 

Phrase: "and"

Phrase: "cotransfection of a dominant negative mutant form of CDK5"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the activation of the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "induced by p35."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C3539715:p35 [Gene or Genome]
Processing 00000000.tx.263: In neurons, p35/CDK5 regulates not only cytoskeletal dynamics and cell migration, but also the cAMP-dependent protein kinase A and the calcium-mediated signaling pathway (14). 

Phrase: "In neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "p35/CDK5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332735:CDK5 [Gene or Genome]

Phrase: "regulates"

Phrase: "not only cytoskeletal dynamics"

Phrase: "and"

Phrase: "cell migration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "but"

Phrase: "also"

Phrase: "the cAMP-dependent protein kinase A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
           cAMP-Dependent Protein Kinase
   853   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "the calcium-mediated signaling pathway"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C2984272:Calcium-Mediated Signaling Pathway [Functional Concept]
           Calcium signaling pathway
   861   C0037083:signaling pathway [Cell Function]
   861   C0086982:Signaling Pathway [Molecular Function]
   844 E C0037080:Signal Pathway [Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
   756   C0600431:calcium-mediated signaling [Cell Function]
           Calcium Signaling

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.264: It also regulates dopamine signaling through phosphorylation of DARPP-32, which converts it into an inhibitor of protein kinase A (25). 

Phrase: "It also"

Phrase: "regulates"

Phrase: "dopamine signaling through phosphorylation of DARPP-32,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037083:Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "which"

Phrase: "converts"

Phrase: "it into an inhibitor of protein kinase A"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   822   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.265: Therefore, we anticipate that in -cells the presence of p35/CDK5 could be involved in the regulation of additional functional pathways. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "anticipate"

Phrase: "that in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the presence of p35/CDK5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "be"

Phrase: "involved in the regulation of additional functional pathways."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0205245:Functional [Functional Concept]
   744   C0542341:Functional [Functional Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1524062:Additional [Functional Concept]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   744   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.266: Our findings also indicate that in insulin-producing -cells, CDK5 activity is predominantly regulated by variations in the expression of its activator p35, which, in turn, is regulated by extracellular glucose concentrations. 

Phrase: "Our findings also"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that in insulin-producing -cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   781   C0030281:Insulin Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "CDK5 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "predominantly"

Phrase: "regulated by variations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205419:variations [Qualitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of its activator p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "which,"

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "is"

Phrase: "regulated by extracellular glucose concentrations."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0427743:concentrations glucose [Laboratory Procedure]
   797   C1287281:concentrations glucose [Laboratory or Test Result]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0521119:Extracellular [Cell Component]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.267: During brain development, the expression of p35 seems to be constitutive, and regulation of CDK5 activity is dependent on its subcellular localization, phosphorylation by other protein kinases such as Abl, and association with other regulatory proteins (Dab1 and Cables) (14). 

Phrase: "During brain development,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1160340:brain development [Organ or Tissue Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "the expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "constitutive,"

Phrase: "and"

Phrase: "regulation of CDK5 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "dependent on its subcellular localization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "phosphorylation by other protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   760   C0031715:Phosphorylation [Molecular Function]

Phrase: "such as Abl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704928:ABL [Gene or Genome]

Phrase: "and"

Phrase: "association with other regulatory proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(Dab1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413898:DAB1 [Gene or Genome]
  1000   C1824492:DAB1 [Gene or Genome]

Phrase: "and"

Phrase: "Cables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0492124:cables [Medical Device]
  1000   C1428446:CABLES [Gene or Genome]

Phrase: ")"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.268: However, up-regulation of p35 at the level of transcription can also occur, as shown after stimulation by laminin in cultured neurons (26), nerve growth factor in PC12 cells (27), neuroregulin in cultured myotubules (23), and chronic cocaine administration to rats (28). 

Phrase: "However,"

Phrase: "up-regulation of p35"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0041904:Up-Regulation [Cell Function,Molecular Function]
   833   C0162493:Up-Regulation [Genetic Function]
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1282911:Up [Spatial Concept]
   770   C1327622:Regulation [Biologic Function]

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "can"

Phrase: "also"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "as"

Phrase: "shown after stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]
   756   C1547282:Show [Intellectual Product]

Phrase: "by laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "nerve growth factor in PC12 cells"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   833   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0007595:cells growth [Cell Function]
   783   C0027882:Nerve Cells [Cell]
   762   C0814002:Neural Growth [Cell Function,Organism Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0027740:Nerve [Tissue]
   753   C0027757:NERVE [Tissue]
   753   C0220844:growth [Physiologic Function]
   753   C1280541:Nerve [Body Part, Organ, or Organ Component]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "neuroregulin in cultured myotubules"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "chronic cocaine administration to rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.269: Our studies raise the possibility that overstimulation of the p35/CDK5 pathway by elevated glucose levels and mislocalization due to cleavage of p35 into a p25 form, lacking its myristoylation domain, may also be a pathogenic mechanism for the glucotoxicity of -cells. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that overstimulation of the p35/CDK5 pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709372:Overstimulation [Conceptual Entity]

Phrase: "by elevated glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "mislocalization due to cleavage of p35"

Phrase: "into a p25 form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "its myristoylation domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "a pathogenic mechanism for the glucotoxicity of -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.270: Overactivation and mislocalization of p35/CDK5 could translate the deleterious effect of a combination of different pathological signals, such as amylin deposition, high levels of plasma lipoproteins, and high glucose levels, as dysregulation of p35/CDK5 in the central nervous system has been associated with the pathological abnormalities found in Alzheimers disease (2, 29) and amyotrophic lateral sclerosis (30). 

Phrase: "Overactivation"

Phrase: "and"

Phrase: "mislocalization of p35/CDK5"

Phrase: "could"

Phrase: "translate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translate [Occupational Activity]

Phrase: "the deleterious effect of a combination of different pathological signals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "such as amylin deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "high levels of plasma lipoproteins,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0583325:Plasma lipoprotein levels [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "high glucose levels,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0428548:glucose levels [Laboratory or Test Result]
   901   C0860803:high glucose [Finding]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "dysregulation of p35/CDK5"

Phrase: "in the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "been"

Phrase: "associated with the pathological abnormalities"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C1521733:Pathological [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1704258:Abnormality [Finding]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "found in Alzheimers disease"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "29"

Phrase: ")"

Phrase: "and"

Phrase: "amyotrophic lateral sclerosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0002736:Amyotrophic Lateral Sclerosis [Disease or Syndrome]
   901   C0154682:Lateral Sclerosis [Disease or Syndrome]
   827   C0036429:Sclerosis [Pathologic Function]
   827   C0205093:Lateral [Spatial Concept]
   755   C0026846:Amyotrophia [Disease or Syndrome]
   755 E C0334135:Sclerotic [Functional Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.271: It is possible that glucose-induced dysregulation of the p35/CDK5 pathway is a pathophysiological mechanism involved in the -cell dysfunction and the predisposition to apoptotic cell death associated with the progression of type 2 diabetes. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that glucose-induced dysregulation of the p35/CDK5 pathway"

Phrase: "is"

Phrase: "a pathophysiological mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the -cell dysfunction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "the predisposition to apoptotic cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012655:Predisposition [Clinical Attribute]
   753   C0220898:Predisposition [Organism Attribute]

Phrase: "associated with the progression of type 2 diabetes."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0242656:progression [Pathologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0449258:Progression [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.272: Several population-based studies have shown that diabetes is associated not only with vascular dementia, but also with Alzheimers type dementia (11, 31, 32, 33). 

Phrase: "Several population-based studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   912   C1709599:Population Based Study [Research Activity]
   875   C0681876:population studies [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "not only with vascular dementia,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0011269:Dementia, Vascular [Disease or Syndrome]
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0205171:Only [Quantitative Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C1518422:Not [Functional Concept]
   760   C1558950:VASCULAR [Finding]
   760   C1720467:Only [Intellectual Product]
   760   C1801960:Vascular [Qualitative Concept]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "but"

Phrase: "also with Alzheimers type dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0002395:alzheimers dementia [Disease or Syndrome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0332307:Type [Qualitative Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(11,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.273: Furthermore, a recent longitudinal population-based cohort study of the Honolulu-Asia Aging Study has clearly demonstrated an association between type 2 diabetes and Alzheimers dementia and has shown that this association is significantly higher among carriers of the APOE 4 allele (12). 

Phrase: "Furthermore,"

Phrase: "a recent longitudinal population-based cohort study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   876   C0023981:Longitudinal Study [Research Activity]
   867   C1709599:Population Based Study [Research Activity]
   858   C0681876:Population Study [Research Activity]
   827   C0009247:Cohort Study [Quantitative Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0599755:Cohort [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "of the Honolulu-Asia Aging Study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0001811:Ageing [Organism Function]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
   779 E C0001779:Age [Organism Attribute]

Phrase: "has"

Phrase: "clearly"

Phrase: "demonstrated"

Phrase: "an association between type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3645563:Association type [Intellectual Product]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimers dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:alzheimers dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "significantly higher among carriers of the APOE 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.274: These and other interesting possibilities await the results of further experimental studies.  

Phrase: "These"

Phrase: "and"

Phrase: "other interesting possibilities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0332149:Possible [Qualitative Concept]
   777   C1705910:Possible [Qualitative Concept]
   777   C2362652:Possible [Qualitative Concept]

Phrase: "await"

Phrase: "the results of further experimental studies."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0683954:results studies [Finding]
   767   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
Processing 00000000.tx.275: Acknowledgments  We thank Linda Fucci for excellent experimental assistance, Melissa Fannon for preparation of the manuscript, and Marion Matzilevich for providing suggestions and helpful criticisms. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Linda Fucci for excellent experimental assistance,"

Phrase: "Melissa Fannon for preparation of the manuscript,"

Phrase: "and"

Phrase: "Marion Matzilevich for providing suggestions"

Phrase: "and"

Phrase: "helpful criticisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870379:criticisms [Social Behavior]
Processing 00000000.tx.276: We thank the Juvenile Diabetes Research Foundation Center for Islet Transplantation at Harvard for providing isolated human islets.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the Juvenile Diabetes Research Foundation Center for Islet Transplantation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0683939:center research [Manufactured Object,Organization]
   742   C0205099:Center [Spatial Concept]

Phrase: "at Harvard"

Phrase: "for providing isolated human islets."
Processing 00000000.tx.277: Footnotes  J.F.H. is an Investigator with the Howard Hughes Medical Institute. 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "J.F.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439133:(f) [Intellectual Product]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "is"

Phrase: "an Investigator with the Howard Hughes Medical Institute."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035173:Investigator [Professional or Occupational Group]
Processing 00000000.tx.278: Abbreviations: CDK, Cyclin-dependent protein kinase; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "CDK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243045:CDK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150557:CDK [Molecular Function]

Phrase: "Cyclin-dependent protein kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   979   C0243045:Cyclin-Dependent Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Cyclin-Dependent Kinase
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.279: siRNA, small interfering RNA. 

Phrase: "siRNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "small interfering RNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.280: Received November 11, 2003. 

Phrase: "Received November 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2003."
Processing 00000000.tx.281: Accepted for publication February 9, 2004.  

Phrase: "Accepted for publication February 9,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2004."
Processing 00000000.tx.282: References Top Abstract Introduction Materials and Methods Results Discussion References  Hoppener JW, Ahren B, Lips CJ 2000 Islet amyloid and type 2 diabetes mellitus. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hoppener JW,"

Phrase: "Ahren B,"

Phrase: "Lips CJ 2000 Islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "type 2 diabetes mellitus."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.283: N Engl J Med 343:411419[Free FullText] Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH 1999 Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. 

Phrase: "N Engl J Med 343"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "411419"

Phrase: "[Free FullText"

Phrase: "] Patrick GN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018381:GN [Geographic Area]

Phrase: "Zukerberg L,"

Phrase: "Nikolic M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "de la Monte S,"

Phrase: "Dikkes P,"

Phrase: "Tsai LH 1999 Conversion of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]

Phrase: "to p25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p25 [Gene or Genome]

Phrase: "deregulates"

Phrase: "Cdk5 activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   933   C2261561:cyclin-dependent kinase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   717   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.284: Nature 402:615622[CrossRef][Medline] Le Dourain NM 1988 On the origin of pancreatic endocrine cells. 

Phrase: "Nature 402"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "615622"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Le Dourain NM 1988 On the origin of pancreatic endocrine cells."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   756   C0229525:Endocrine Cells [Cell]
   754   C0023172:LE Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C0014136:Endocrine [Body System]
   738   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   738   C0079946:origin [Classification]
   738   C0312860:NM [Cell Function]
   738   C0439090:LE [Idea or Concept]
   738   C0439659:Origin [Temporal Concept]
   738   C0521425:Endocrine [Functional Concept]
   738   C1423767:LE [Gene or Genome]
   738   C1550512:origin [Intellectual Product]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.285: Cell 53:169171[Medline] Alpert S, Hanahan D, Teitelman G 1988 Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. 

Phrase: "Cell 53"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "169171"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alpert S,"

Phrase: "Hanahan D,"

Phrase: "Teitelman G 1988 Hybrid insulin genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C0598468:hybrid gene [Gene or Genome]
   810   C1337112:Insulin Gene [Gene or Genome]
   799   C0017337:Genes [Gene or Genome]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a developmental lineage for pancreatic endocrine cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0282637:Cell Lineage [Idea or Concept]
   748   C1881379:Lineage [Conceptual Entity]

Phrase: "and"

Phrase: "imply"

Phrase: "a relationship with neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.286: Cell 53:295308[Medline] Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J, Bucchini D 1993 Differential expression of the two non-allelic proinsulin genes in the developing mouse embryo. 

Phrase: "Cell 53"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "295308"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Deltour L,"

Phrase: "Leduque P,"

Phrase: "Blume N,"

Phrase: "Madsen O,"

Phrase: "Dubois P,"

Phrase: "Jami J,"

Phrase: "Bucchini D 1993 Differential expression of the two non-allelic proinsulin genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C1519516:Differential Gene Expression [Genetic Function]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "in the developing mouse embryo."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0013935:Embryo [Embryonic Structure]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.287: Proc Natl Acad Sci USA 90:527531[Abstract] Devaskar SU, Singh BS, Carnaghi LR, Rajakumar PA, Giddins SJ 1993 Insulin-II gene expression in rat central nervous system. 

Phrase: "Proc Natl Acad Sci USA 90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439083:>90 [Quantitative Concept]
   799   C0439087:<90 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "527531"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Devaskar SU,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705534:SU [Idea or Concept]

Phrase: "Singh BS,"

Phrase: "Carnaghi LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Rajakumar PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Giddins SJ 1993 Insulin-II gene expression in rat central nervous system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017262:Gene Expression [Genetic Function]
   751   C1337112:Insulin Gene [Gene or Genome]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.288: Regul Pept 48:5563[CrossRef][Medline] Perez-Villamil B, Schwartz PT, Vallejo M 1999 The pancreatic homeodomain transcription factor IDX1/IPF1 is expressed in neural cells during brain development. 

Phrase: "Regul Pept 48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "5563"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perez-Villamil B,"

Phrase: "Schwartz PT,"

Phrase: "Vallejo M 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "The pancreatic homeodomain transcription factor IDX1/IPF1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1826562:HOMEODOMAIN TRANSCRIPTION FACTOR IPF1 [Gene or Genome]
           IPF1

Phrase: "is"

Phrase: "expressed in neural cells"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   816   C0027882:Neural cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0599851:Neural [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   715 E C0027740:Nerve [Tissue]
   715 E C0027757:NERVE [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "during brain development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1160340:brain development [Organ or Tissue Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.289: Endocrinology 140:38573860[Abstract/Free FullText] Ashford ML, Boden PR, Treherne IM 1990 Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K channels. 

Phrase: "Endocrinology 140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "38573860"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ashford ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Boden PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Treherne IM 1990 Glucose-induced excitation of hypothalamic neurones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0549255:Excitation [Activity]
   720   C0234073:Neuronal excitation [Physiologic Function]

Phrase: "is"

Phrase: "mediated by ATP-sensitive K channels."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0332324:Sensitive [Functional Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1550474:sensitive [Idea or Concept]
   753   C1708601:K' [Quantitative Concept]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.290: Pflugers Arch 415:479483[Medline] Ashford ML, Boden PR, Treherne IM 1990 Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels. 

Phrase: "Pflugers Arch 415"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "479483"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ashford ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Boden PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Treherne IM 1990 Tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   756 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "excites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excite [Activity]

Phrase: "rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   725   C0234074:Neuronal inhibition [Organ or Tissue Function]
   711   C0027882:Neurone [Cell]

Phrase: "of ATP-K+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.291: Br J Pharmacol 101:531540[Abstract] Thor S, Ericson J, Brannstrom T, Edlund T 1991 The homeodomain LIM protein isl-1 is expressed in a subset of neurons and endocrine cells in the adult rat. 

Phrase: "Br J Pharmacol 101"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "531540"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Thor S,"

Phrase: "Ericson J,"

Phrase: "Brannstrom T,"

Phrase: "Edlund T 1991"

Phrase: "The homeodomain LIM protein isl-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1334337:LIM-1 [Gene or Genome]
   875   C1705893:LIM-1 [Gene or Genome]
   840   C1416480:ISL1 [Gene or Genome]
   804   C0020750:ISL [Geographic Area]

Phrase: "is"

Phrase: "expressed in a subset of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027882:Neurons [Cell]
   753   C1515021:Subset [Classification]

Phrase: "and"

Phrase: "endocrine cells in the adult rat."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0229525:Endocrine Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0014136:Endocrine [Body System]
   753   C0521425:Endocrine [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.292: Neuron 7:881889[Medline] Janson J, Laedtke T, Parisi JE, OBrien P, Petersen RC, Butler PC 2004 Increased risk of type 2 diabetes in Alzheimer disease. 

Phrase: "Neuron 7"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "881889"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Janson J,"

Phrase: "Laedtke T,"

Phrase: "Parisi JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "OBrien P,"

Phrase: "Petersen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Butler PC 2004 Increased risk of type 2 diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1171304:diabetes risk [Quantitative Concept]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.293: Diabetes 53:474481[Abstract/Free FullText] Peila R, Rodriguez BL, Launer LJ 2002 Type 2 diabetes, APOE gene, and risk for dementia and related pathologies. 

Phrase: "Diabetes 53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "474481"

Phrase: "[Abstract/Free FullText"

Phrase: "] Peila R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rodriguez BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Launer LJ 2002 Type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0011860:Type 2 Diabetes [Disease or Syndrome]
   839   C1320657:type diabetes [Finding]
   827   C0441730:Type 2 [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0011849:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "APOE gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412481:APOE gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "risk for dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "related pathologies."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0030664:Pathologies [Biomedical Occupation or Discipline]
   827 E C0205469:pathology [Functional Concept]
   827 E C0677042:pathology [Pathologic Function]
   777 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.294: Diabetes 51:12561262[Abstract/Free FullText] Andrews B, Measday V 1998 The cyclin family of budding yeast: abundant use of a good idea. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12561262"

Phrase: "[Abstract/Free FullText"

Phrase: "] Andrews B,"

Phrase: "Measday V 1998"

Phrase: "The cyclin family of budding yeast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "abundant use of a good idea."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
Processing 00000000.tx.295: Trends Genet 14:6672[CrossRef][Medline] Dhavan R, Tsai LH 2001 A decade of cdk5. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "6672"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dhavan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tsai LH 2001"

Phrase: "A decade of cdk5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2981279:Decade [Quantitative Concept]
Processing 00000000.tx.296: Nat Rev Mol Cell Biol 2:749759[CrossRef][Medline] Van den Heuvel S, Harlow E 1993 Distinct roles for cyclin-dependent kinases in cell cycle control. 

Phrase: "Nat Rev Mol Cell Biol 2"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   895   C0796518:NAT-2 [Gene or Genome]
   895   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1705514:NAT-2 [Gene or Genome]
   799   C0007634:Cell [Cell]
   799   C0027960:Mole [Neoplastic Process]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1456781:mole [Neoplastic Process]
   799   C1704653:Cell [Medical Device]
   799   C1824986:mol [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]
   799   C2347961:Rev. [Professional or Occupational Group]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "749759"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Van den Heuvel S,"

Phrase: "Harlow E 1993 Distinct roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0035820:Roles [Social Behavior]
   771 E C1705810:Role [Conceptual Entity]

Phrase: "for cyclin-dependent kinases in cell cycle control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   845   C1155872:Cell Cycle Control [Cell Function]
   795   C0243148:control [Qualitative Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.297: Science 262:20502054[Medline] Nikolic M, Tsai LH 2000 Activity and regulation of p35/Cdk5 kinase complex. 

Phrase: "Science 262"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "20502054"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nikolic M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tsai LH 2000 Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "regulation of p35/Cdk5 kinase complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.298: Methods Enzymol 325:200213[Medline] Meijer L, Borgne A, Mulner O, P. 

Phrase: "Methods Enzymol 325"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "200213"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Meijer L,"

Phrase: "Borgne A,"

Phrase: "Mulner O,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.299: Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP 1997 Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. 

Phrase: "Chong JP,"

Phrase: "Blow JJ,"

Phrase: "Inagaki N,"

Phrase: "Inagaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Delcros JG,"

Phrase: "Moulinoux JP 1997 Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "cellular effects of roscovitine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "selective inhibitor of the cyclin-dependent kinases cdc2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0919418:Cyclin-Dependent Kinase Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cyclin Kinase Inhibitor
   814   C1152568:cyclin dependent kinase inhibitor [Molecular Function]
   814   C1511576:Cyclin-Dependent Kinase Inhibitor [Pharmacologic Substance]
   793   C0292198:Cyclin-Dependent Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   750   C3537023:kinase inhibitor [Molecular Function]
   750   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "cdk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108855:CDK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332733:CDK2 [Gene or Genome]

Phrase: "and"

Phrase: "cdk5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.300: Eur J Biochem 243:527536[Abstract] Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP 1997 Biochemical and cellular effects of roscovotine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. 

Phrase: "Eur J Biochem 243"

Phrase: ":"

Phrase: "527536"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Meijer L,"

Phrase: "Borgne A,"

Phrase: "Mulner O,"

Phrase: "Chong JP,"

Phrase: "Blow JJ,"

Phrase: "Inagaki N,"

Phrase: "Inagaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Delcros JG,"

Phrase: "Moulinoux JP 1997 Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "cellular effects of roscovotine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "selective inhibitor of the cyclin-dependent kinases cdc2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0919418:Cyclin-Dependent Kinase Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cyclin Kinase Inhibitor
   814   C1152568:cyclin dependent kinase inhibitor [Molecular Function]
   814   C1511576:Cyclin-Dependent Kinase Inhibitor [Pharmacologic Substance]
   793   C0292198:Cyclin-Dependent Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   750   C3537023:kinase inhibitor [Molecular Function]
   750   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "cdk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108855:CDK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332733:CDK2 [Gene or Genome]

Phrase: "and"

Phrase: "cdk5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]
Processing 00000000.tx.301: Eur J Biochem 243:527536[Abstract] Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH 1994 A brain-specific activator of cyclin-dependent kinase 5. 

Phrase: "Eur J Biochem 243"

Phrase: ":"

Phrase: "527536"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lew J,"

Phrase: "Huang QQ,"

Phrase: "Qi Z,"

Phrase: "Winkfein RJ,"

Phrase: "Aebersold R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hunt T,"

Phrase: "Wang JH 1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268060:JH [Disease or Syndrome]
   827   C1415529:JH [Gene or Genome]

Phrase: "A brain-specific activator of cyclin-dependent kinase 5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C2247123:kinase activator [Molecular Function]
Processing 00000000.tx.302: Nature 371:423426[CrossRef][Medline] Chou KC, Watenpaugh KD, Heinrikson RL 1999 A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. 

Phrase: "Nature 371"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "423426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chou KC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]

Phrase: "Watenpaugh KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Heinrikson RL 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419337:RL [Gene or Genome]
   827   C3539667:RL [Gene or Genome]

Phrase: "A model of the complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "between cyclin-dependent kinase 5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "the activation domain of neuronal Cdk5 activator."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C1879547:Activation [Activity]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.303: Biochem Biophys Res Commun 259:420428[CrossRef][Medline] Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH 1995 An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. 

Phrase: "Biochem Biophys Res Commun 259"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "420428"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tang D,"

Phrase: "Yeung J,"

Phrase: "Lee KY,"

Phrase: "Matsushita M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Matsui H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tomizawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hatase O,"

Phrase: "Wang JH 1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268060:JH [Disease or Syndrome]
   827   C1415529:JH [Gene or Genome]

Phrase: "An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0597298:Isoform [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.304: J Biol Chem 270:2689726903[Abstract/Free FullText] Gao CY, Zakeri Z, Zhu Y, He H, Zelenka PS 1997 Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2689726903"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gao CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Zakeri Z,"

Phrase: "Zhu Y,"

Phrase: "He H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zelenka PS 1997 Expression of Cdk5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "Cdk5-associated kinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   911   C2261561:cyclin-dependent kinase activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   710   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]

Phrase: "in the developing rat lens."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0023317:Lens [Body Part, Organ, or Organ Component]
   827   C0023318:Lens [Medical Device]
   827   C0996842:Lens [Plant]
   827   C1278892:Lens [Body Part, Organ, or Organ Component]
Processing 00000000.tx.305: Dev Genet 20:267275[CrossRef][Medline] Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY 2001 Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. 

Phrase: "Dev Genet 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "267275"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fu AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Fu WY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043287:WY [Geographic Area]

Phrase: "Cheung J,"

Phrase: "Tsim KW,"

Phrase: "Ip FC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2983605:FC [Activity]

Phrase: "Wang JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Ip NY 2001 Cdk5"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   877   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   845   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0027976:NY [Geographic Area]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0851827:Dependent [Qualitative Concept]
   795   C1150565:cyclin [Molecular Function]
   795   C1701901:Dependent [Qualitative Concept]
   795   C1879958:NY [Intellectual Product]
   795   C3244310:dependent [Functional Concept]

Phrase: "is"

Phrase: "involved in neuregulin-induced AChR expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205263:Induced [Functional Concept]
   753   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1314939:Involved [Functional Concept]

Phrase: "at the neuromuscular junction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027869:Neuromuscular Junction [Cell Component]
   861   C0205144:Junction [Spatial Concept]
   861   C1706311:Junction [Medical Device]
   861   C1979768:Neuromuscular [Qualitative Concept]
Processing 00000000.tx.306: Nat Neurosci 4:374381[CrossRef][Medline] Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C 2001 Cyclin-dependent kinase 5 promotes insulin exocytosis. 

Phrase: "Nat Neurosci 4"

Phrase: ":"

Phrase: "374381"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lilja L,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "SN,"

Phrase: "Webb DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Juntti-Berggren L,"

Phrase: "Berggren PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Bark C 2001 Cyclin-dependent kinase 5"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   877   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   845   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0234875:bark [Organism Attribute]
   795   C0851827:Dependent [Qualitative Concept]
   795   C1150565:cyclin [Molecular Function]
   795   C1701901:Dependent [Qualitative Concept]
   795   C2700441:Bark [Plant]
   795   C3244310:dependent [Functional Concept]
   740 E C0001613:Cortical [Body Part, Organ, or Organ Component]
   740 E C0007776:Cortical [Body Part, Organ, or Organ Component]
   740 E C0022655:Cortical [Body Part, Organ, or Organ Component]
   740 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   740 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "insulin exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.307: J Biol Chem 276:3419934205[Abstract/Free FullText] Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings Jr HC, Nairn AC, Greengard P 1999 Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3419934205"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bibb JA,"

Phrase: "Snyder GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Nishi A,"

Phrase: "Yan Z,"

Phrase: "Meijer L,"

Phrase: "Fienberg AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Tsai LH,"

Phrase: "Kwon YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Girault JA,"

Phrase: "Czernik AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Huganir RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Hemmings Jr HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   827   C1413512:Hc [Gene or Genome]

Phrase: "Nairn AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Greengard P 1999 Phosphorylation of DARPP-32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "by Cdk5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "dopamine signalling in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C3537152:signalling [Biologic Function]
   737 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.308: Nature 402:669671[CrossRef][Medline] Harada T, Morooka T, Ogawa S, Nishida E 2001 ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. 

Phrase: "Nature 402"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "669671"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harada T,"

Phrase: "Morooka T,"

Phrase: "Ogawa S,"

Phrase: "Nishida E 2001 ERK"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "a neuron-specific activator of Cdk5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C2247123:kinase activator [Molecular Function]

Phrase: "through induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of Egr1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414314:EGR1 [Gene or Genome]
  1000   C1566493:EGR-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.309: Nat Cell Biol 3:453459[CrossRef][Medline] Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Caceres A 1998 Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. 

Phrase: "Nat Cell Biol 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "453459"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paglini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pigino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kunda P,"

Phrase: "Morfini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Maccioni R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Quiroga S,"

Phrase: "Ferreira A,"

Phrase: "Caceres"

Phrase: "A 1998 Evidence for the participation of the neuron-specific CDK5 activator P35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   749   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "during laminin-enhanced axonal growth."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   825   C1749784:axon growth [Organ or Tissue Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.310: J Neurosci 18:98589869[Abstract/Free FullText] Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P 2001 Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. 

Phrase: "J Neurosci 18"

Phrase: ":"

Phrase: "98589869"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bibb JA,"

Phrase: "Chen J,"

Phrase: "Taylor JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Svenningsson P,"

Phrase: "Nishi A,"

Phrase: "Snyder GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Yan Z,"

Phrase: "Sagawa ZK,"

Phrase: "Ouimet CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "Nairn AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Nestler EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Greengard P 2001 Effects of chronic exposure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "to cocaine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009170:Cocaine [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "regulated by the neuronal protein Cdk5."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   790   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Cyclin-Dependent Protein Kinases
   762   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1150565:cyclin [Molecular Function]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
Processing 00000000.tx.311: Nature 410:376380[CrossRef][Medline] Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF 1998 Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimers disease neurofibrillary degeneration. 

Phrase: "Nature 410"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "376380"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pei JJ,"

Phrase: "Grundke-Iqbal I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iqbal K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bogdanovic N,"

Phrase: "Winblad B,"

Phrase: "Cowburn RF 1998 Accumulation of cyclin-dependent kinase 5"

Phrase: "(cdk5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: ")"

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "with early stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C2363430:early stages [Temporal Concept]
   983 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of Alzheimers disease neurofibrillary degeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   812   C0011164:Degeneration [Pathologic Function]
   812   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.312: Brain Res 797:267277[CrossRef][Medline] Nguyen MD, Lariviere RC, Julien JP 2001 Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. 

Phrase: "Brain Res 797"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "267277"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nguyen MD,"

Phrase: "Lariviere RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Julien JP 2001 Deregulation of Cdk5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880287:Deregulation [Activity]

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of ALS"

Phrase: ":"

Phrase: "toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "alleviated by perikaryal neurofilament inclusions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027834:Neurofilament [Cell Component]
   726   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.313: Neuron 30:135147[Medline] Kuusisto J, Koivisto K, Mykkanen L, Helkaka E, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laasko M 1997 Association between features of the insulin resistance syndrome and Alzheimers disease independently of apolipoprotein e4 phenotype: cross-sectional population-based study. 

Phrase: "Neuron 30"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "135147"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuusisto J,"

Phrase: "Koivisto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mykkanen L,"

Phrase: "Helkaka E,"

Phrase: "Vanhanen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hanninen T,"

Phrase: "Kervinen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kesaniemi YA,"

Phrase: "Riekkinen PJ,"

Phrase: "Laasko M 1997 Association between features of the insulin resistance syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0004083:Association [Mental Process]
   738   C0439849:Association [Qualitative Concept]
   738   C0596306:Association [Phenomenon or Process]
   738   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimers disease independently of apolipoprotein e4 phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]

Phrase: ":"

Phrase: "cross-sectional population-based study."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   911   C0010362:Cross-Sectional Study [Research Activity]
   884   C1709599:Population Based Study [Research Activity]
   853   C0681876:Population Study [Research Activity]
   804   C0032659:Population [Quantitative Concept]
   804   C0205155:Sectional [Spatial Concept]
   804   C0552389:cross sections [Spatial Concept]
   804   C0557651:Study [Manufactured Object]
   804   C1257890:Population [Population Group]
   804   C1527178:Based [Functional Concept]
   804   C1705938:Based [Idea or Concept]
   804   C2603343:Study [Research Activity]
   804   C2828360:Cross [Conceptual Entity]
   771 E C0002055:base [Inorganic Chemical]
   771 E C0178499:Base [Chemical Viewed Functionally]
   771 E C1880279:Base [Biomedical or Dental Material]
   733 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   733 E C1522472:Section [Substance]
   733 E C1552923:Section [Quantitative Concept]
   733 E C1705191:Section [Physical Object]
Processing 00000000.tx.314: Br Med J 315:10451049[Abstract/Free FullText] Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, OBrien PC, Palumbo PJ 1997 Risk of dementia among persons with diabetes mellitus: a population-based cohort study. 

Phrase: "Br Med J 315"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "10451049"

Phrase: "[Abstract/Free FullText"

Phrase: "] Leibson CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Rocca WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Hanson VA,"

Phrase: "Cha R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kokmen E,"

Phrase: "OBrien PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Palumbo PJ 1997 Risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "among persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027361:Persons [Population Group]
   966 E C2347489:Person [Group]
   916 E C1519021:Personal [Organism Attribute]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "a population-based cohort study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0009247:Cohort Study [Quantitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0599755:Cohort [Population Group]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.315: Am J Epidemiol 145:301308[Abstract] Ott A, Stolk RP, van Hardkamp FH, Pols AP, Hofman A, Breteler MMB 1999 Diabetes mellitus and the risk of dementia. 

Phrase: "Am"

Phrase: "J Epidemiol 145"

Phrase: ":"

Phrase: "301308"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ott A,"

Phrase: "Stolk RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "van Hardkamp FH,"

Phrase: "Pols AP,"

Phrase: "Hofman A,"

Phrase: "Breteler MMB 1999 Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.316: Neurology 53:19371942[Abstract/Free FullText]

Phrase: "Neurology 53"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "19371942"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

